<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Pediatr.</journal-id>
<journal-title>Frontiers in Pediatrics</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Pediatr.</abbrev-journal-title>
<issn pub-type="epub">2296-2360</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fped.2024.1405110</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Pediatrics</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Analysis of research hotspots and trends in pediatric ophthalmopathy based on 10 years of WoSCC literature</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes"><name><surname>Jia</surname><given-names>Qianfang</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="author-notes" rid="an1"><sup>&#x2020;</sup></xref><uri xlink:href="https://loop.frontiersin.org/people/2542394/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes"><name><surname>Wang</surname><given-names>Xiaofang</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="author-notes" rid="an1"><sup>&#x2020;</sup></xref><uri xlink:href="https://loop.frontiersin.org/people/2518595/overview" />
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author"><name><surname>Li</surname><given-names>Xiwan</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" corresp="yes"><name><surname>Xie</surname><given-names>Cuijuan</given-names></name>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref><uri xlink:href="https://loop.frontiersin.org/people/2293179/overview" />
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Qing</given-names></name>
<xref ref-type="aff" rid="aff5"><sup>5</sup></xref><uri xlink:href="https://loop.frontiersin.org/people/2451264/overview" />
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" corresp="yes"><name><surname>Mu</surname><given-names>Jingfeng</given-names></name>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref><uri xlink:href="https://loop.frontiersin.org/people/2561580/overview" />
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes"><name><surname>Yang</surname><given-names>Weihua</given-names></name>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref><uri xlink:href="https://loop.frontiersin.org/people/1439952/overview" />
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1"><label><sup>1</sup></label><institution>Department of Children Rehabilitation, First Affiliated Hospital of Xinxiang Medical University</institution>, <addr-line>Xinxiang</addr-line>, <country>China</country></aff>
<aff id="aff2"><label><sup>2</sup></label><institution>Xinxiang Autism Integration Education Engineering Technology Research Center</institution>, <addr-line>Xinxiang</addr-line>, <country>China</country></aff>
<aff id="aff3"><label><sup>3</sup></label><institution>Hebei University of Chinese Medicine</institution>, <addr-line>Shijiazhuang</addr-line>, <country>China</country></aff>
<aff id="aff4"><label><sup>4</sup></label><institution>Shenzhen Eye Institute, Shenzhen Eye Hospital, Jinan University</institution>, <addr-line>Shenzhen</addr-line>, <country>China</country></aff>
<aff id="aff5"><label><sup>5</sup></label><institution>The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang Medical University</institution>, <addr-line>Xinxiang</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by"><p><bold>Edited by:</bold> Shi Song Rong, Harvard Medical School, United States</p></fn>
<fn fn-type="edited-by"><p><bold>Reviewed by:</bold> Jos&#x00E9; Aparecido Da Silva, University of Brasilia, Brazil</p>
<p>Thiago Gon&#x00E7;alves dos Santos Martins, Federal University of S&#x00E3;o Paulo, Brazil</p></fn>
<corresp id="cor1"><label>&#x002A;</label><bold>Correspondence:</bold> Weihua Yang <email>benben0606@139.com</email> Jingfeng Mu <email>1014120300@qq.com</email> Cuijuan Xie <email>xlja2379@126.com</email></corresp>
<fn fn-type="equal" id="an1"><label><sup>&#x2020;</sup></label><p>These authors have contributed equally to this work and share first authorship</p></fn>
</author-notes>
<pub-date pub-type="epub"><day>30</day><month>05</month><year>2024</year></pub-date>
<pub-date pub-type="collection"><year>2024</year></pub-date>
<volume>12</volume><elocation-id>1405110</elocation-id>
<history>
<date date-type="received"><day>22</day><month>03</month><year>2024</year></date>
<date date-type="accepted"><day>20</day><month>05</month><year>2024</year></date>
</history>
<permissions>
<copyright-statement>&#x00A9; 2024 Jia, Wang, Li, Xie, Zhang, Mu and Yang.</copyright-statement>
<copyright-year>2024</copyright-year><copyright-holder>Jia, Wang, Li, Xie, Zhang, Mu and Yang</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract>
<sec><title>Background</title>
<p>Ophthalmopathy occurring in childhood can easily lead to irreversible visual impairment, and therefore a great deal of clinical and fundamental researches have been conducted in pediatric ophthalmopathy. However, a few studies have been performed to analyze such large amounts of research using bibliometric methods. This study intended to apply bibliometric methods to analyze the research hotspots and trends in pediatric ophthalmopathy, providing a basis for clinical practice and scientific research to improve children&#x0027;s eye health.</p>
</sec>
<sec><title>Methods</title>
<p>Publications related to pediatric ophthalmopathy were searched and identified in the Web of Science Core Collection (WoSCC) database. Bibliometric and visualized analysis was performed using the WoSCC analysis system and CiteSpace.6.2.6 software, and high-impact publications were analyzed.</p>
</sec>
<sec><title>Results</title>
<p>This study included a total of 7,177 publications from 162 countries and regions. Of these, 2,269 from the United States and 1,298 from China. The centrality and H-index were highest in the United States at 0.27 and 66, respectively. The University of London and Harvard University had the highest H-index at 37. Freedman,Sharon F published 55 publications, with the highest H-index at 19. The emerging burst keyword in 2020&#x2013;2023 was &#x201C;eye tracking,&#x201D; and the burst keywords in 2021&#x2013;2023 were &#x201C;choroidal thickness,&#x201D; &#x201C;pediatric ophthalmology,&#x201D; &#x201C;impact&#x201D; and &#x201C;childhood glaucoma.&#x201D; Retinopathy of prematurity, myopia, retinoblastoma and uveitis in juvenile idiopathic arthritis were the main topics in the high-impact publications, with clinical studies in the majority, especially in retinopathy of prematurity.</p>
</sec>
<sec><title>Conclusion</title>
<p>Eye health in children is a research hotspot, with the United States publishing the largest number of papers and having the greatest influence in research on pediatric ophthalmopathy, and China coming in second. The University of London and Stanford University had the greatest influence. Freedman, Sharon F was the most influential author. Furthermore, &#x201C;choroidal thickness,&#x201D; &#x201C;pediatric ophthalmology,&#x201D; &#x201C;impact,&#x201D; &#x201C;childhood glaucoma&#x201D; and &#x201C;eye tracking&#x201D;are the latest hotspots in the field of pediatric ophthalmopathy. These hotspots represent hot diseases, hot technologies and holistic concepts, which are exactly the research trends in the field of pediatric ophthalmopathy, providing guidance and grounds for clinical practice and scientific research on children&#x0027;s eye health.</p>
</sec>
</abstract>
<kwd-group>
<kwd>pediatric</kwd>
<kwd>ophthalmopathy</kwd>
<kwd>bibliometric</kwd>
<kwd>visualization</kwd>
<kwd>CiteSpace</kwd>
<kwd>hotspots</kwd>
<kwd>trends</kwd>
</kwd-group>
<contract-num rid="cn001">SZGSP014</contract-num>
<contract-num rid="cn002">SZSM202311012</contract-num>
<contract-num rid="cn003">JCYJ20230807114608016</contract-num>
<contract-sponsor id="cn001">Shenzhen Fund for Guangdong Provincial High-level Clinical Key Specialties</contract-sponsor>
<contract-sponsor id="cn002">Sanming Project of Medicine in Shenzhen<named-content content-type="fundref-id">10.13039/501100012151</named-content></contract-sponsor>
<contract-sponsor id="cn003">Shenzhen Science and Technology Program<named-content content-type="fundref-id">10.13039/501100017610</named-content></contract-sponsor>
<counts>
<fig-count count="6"/>
<table-count count="6"/><equation-count count="0"/><ref-count count="74"/><page-count count="0"/><word-count count="0"/></counts><custom-meta-wrap><custom-meta><meta-name>section-at-acceptance</meta-name><meta-value>Children and Health</meta-value></custom-meta></custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro"><label>1</label><title>Introduction</title>
<p>Ophthalmopathy including include myopia, retinopathy, and glaucoma during childhood can significantly impact the development of visual, potentially leading to irreversible visual impairment, seriously affecting children&#x0027;s health and even contributing to long-term adverse social consequences. Specifically, myopia, in particular may affect children&#x0027;s quality of life and even posing a risk for blindness (<xref ref-type="bibr" rid="B1">1</xref>&#x2013;<xref ref-type="bibr" rid="B3">3</xref>). Retinopathy of prematurity, a vasculopathy affecting the developing retinal vasculature in premature newborns, can result in retinal detachment, visual impairment, and blindness (<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B5">5</xref>). Glaucoma, which, if untreated timely, can cause sustained intraocular pressure increases, leading to optic nerve damage and vision loss (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B7">7</xref>). Thus, timely diagnosis and treatment of ocular diseases in children are crucial, and modern technologies are required to apply in pediatric ophthalmopathy (<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B9">9</xref>). A holistic understanding of the current status and hotspots of research in this area can better provide reference for clinical workers and directions for researchers in pediatric ophthalmopathy.</p>
<p>Bibliometric analysis, first introduced in 1987, has been extensively applied across various fields to objectively assess research dynamics and frontiers, uncover available information in specific areas, and explore future research directions (<xref ref-type="bibr" rid="B10">10</xref>&#x2013;<xref ref-type="bibr" rid="B12">12</xref>). While earlier studies have employed bibliometric methods to analyze pediatric ophthalmopathy, they have primarily focused on individual diseases, such as glaucoma (<xref ref-type="bibr" rid="B13">13</xref>), retinopathy of prematurity (<xref ref-type="bibr" rid="B14">14</xref>), and retinoblastoma (<xref ref-type="bibr" rid="B15">15</xref>), failing to offer a comprehensive overview and evaluation of pediatric ophthalmopathy. Consequently, this study conducted a bibliometric and visualized analysis of pediatric ophthalmopathy research to explore the research hotspots and trends in pediatric ophthalmopathy. Additionally, the Web of Science Core Collection (WoSCC) is the standard data set underpinning the journal impact metrics found in the Journal Citation Reports, providing high quality literature (<xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B17">17</xref>); and the last decade literature reflects the latest research hotspots and trends that are more valuable to researchers as a research guide. Therefore, the data of this study was based on the literature of Woscc for the last decade to explore the research hotspots and trends in pediatric ophthalmopathy, potentially guiding future research in this field.</p>
</sec>
<sec id="s2" sec-type="methods"><label>2</label><title>Materials and methods</title>
<p>The research methods included three parts: identifying the search strategy, selecting the publications and analyzing the data. In efforts to demonstrate research hotspots and trends in pediatric ophthalmopathy, high-quality, newly current mainstream publications from the WoSCC database need to be selected for data analysis. The search strategy included limiting the database, search terms, language, document type and publication date, and the specific search strategy was as follows: the database was selected from the WoSCC database, with topic&#x2009;&#x003D;&#x2009;(&#x201C;pediatric&#x002A;&#x201D; or &#x201C;paediatric&#x002A;&#x201D; or &#x201C;child&#x002A;&#x201D; or &#x201C;infant&#x002A;&#x201D; or &#x201C;adolescent&#x002A;&#x201D; or &#x201C;neonate&#x002A;&#x201D; or &#x201C;inborn&#x201D;) and title&#x2009;&#x003D;&#x2009;(&#x201C;eye&#x002A;&#x201D; or &#x201C;ophthalm&#x002A;&#x201D; or &#x201C;retin&#x002A;&#x201D; or &#x201C;cornea&#x002A;&#x201D; or &#x201C;keratitis&#x201D; or &#x201C;uveal&#x201D; or &#x201C;uveitis&#x201D; or &#x201C;scleral&#x201D; or &#x201C;orbital&#x201D; or &#x201C;orbitopathy&#x201D;or &#x201C;glaucoma&#x201D;), with a language restriction of English, an document type of article, and a publication date period from January 1, 2014 to December 31, 2023. The data was checked separately by two researchers. Further, secondary selection was performed based on document type and article content, Proccedings papers, review articles, book chapters, early eccess, editorial materials, letters, meeting abstracts, corrections, data papers and retracted publications were excluded on the basis of document type. The content of publications matching the doucument type was then screened based on the each title and abstract. If unsure, the full text was downloaded and excluded based on content. Publications that were not relevant to the topic of pediatric ophthalmopathy were excluded, such as pediatrics alone or eye disease alone. Bibliometric and visualized analysis was performed on the included publications, and <xref ref-type="fig" rid="F1">Figure&#x00A0;1</xref> shows the detailed flowchart. In the data analysis, CiteSpace.6.2.6 was used to analyze the collaborative network of countries or regions, institutions, journals, as well as keywords and research categories, and the analysis function of the WoSCC database was used to analyze the number of annual publications and the number of national or regional publications. At the same time, high-impact publications were analyzed in depth and detail to further demonstrate the popular research on children&#x0027;s eye diseases.</p>
<fig id="F1" position="float"><label>Figure 1</label>
<caption><p>Frame flow diagram showing the detailed selection criteria and bibliometric analysis steps for the study of pediatric ophthalmopathy.</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fped-12-1405110-g001.tif"/>
</fig>
</sec>
<sec id="s3" sec-type="results"><label>3</label><title>Results</title>
<sec id="s3a"><label>3.1</label><title>Annual number of publications</title>
<p>Following the identification and selection process, this study encompassed 7,177 publications specifically addressing pediatric ophthalmopathy. Over the past decade, the annual publication count had consistently exceeded 500, with a notable surge in recent years, peaking at over 1,000 in 2021 and 2022. While the number of publications for 2023 was slightly lower than 2022 due to some articles not yet being publicly available online at the time of data collection. The trend in annual publication counts for pediatric ophthalmopathy over the last decade is illustrated in <xref ref-type="fig" rid="F2">Figure&#x00A0;2</xref>.</p>
<fig id="F2" position="float"><label>Figure 2</label>
<caption><p>Annual number of publications on pediatric ophthalmopathy.</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fped-12-1405110-g002.tif"/>
</fig>
</sec>
<sec id="s3b"><label>3.2</label><title>Countries or regions</title>
<p>These publications originate from 162 countries and regions. <xref ref-type="fig" rid="F3">Figure&#x00A0;3</xref> presents a collaborative network graph for each country or region, with the default settings of CiteSpace. The size of each label and node region in <xref ref-type="fig" rid="F3">Figure&#x00A0;3</xref> is proportional to the number of publications. The United States (2,269), the People&#x0027;s Republic of China (1,298), and India (649) had the largest labels and node regions, indicating the highest publication volumes. Connections between nodes signify cooperative efforts between countries or regions, with more connections indicating closer collaboration. <xref ref-type="table" rid="T1">Table&#x00A0;1</xref> provides details for the top 10 countries or regions based on publication numbers, including centrality scores that reflect the strength of their cooperation and H-indexes that measure influence. The United States lead with the highest centrality (0.27) and H-index (66); China followed with a lower centrality but maintains a significant presence; England, with 561 publications, had a high centrality of 0.19 and an H-index of 40.</p>
<fig id="F3" position="float"><label>Figure 3</label>
<caption><p>Cooperation of countries or regions that contributed to publications on pediatric ophthalmopathy.</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fped-12-1405110-g003.tif"/>
</fig>
<table-wrap id="T1" position="float"><label>Table 1</label>
<caption><p>Top 10 countries or regions with publications on pediatric ophthalmopathy.</p></caption>
<table frame="hsides" rules="groups">
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
</colgroup>
<thead>
<tr>
<th valign="top" align="left">Rank</th>
<th valign="top" align="left">Countries or regions</th>
<th valign="top" align="center">Counts</th>
<th valign="top" align="center">Centrality</th>
<th valign="top" align="center">H-index</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">1</td>
<td valign="top" align="left">United States</td>
<td valign="top" align="center">2,269</td>
<td valign="top" align="center">0.27</td>
<td valign="top" align="center">66</td>
</tr>
<tr>
<td valign="top" align="left">2</td>
<td valign="top" align="left">China</td>
<td valign="top" align="center">1,298</td>
<td valign="top" align="center">0.01</td>
<td valign="top" align="center">43</td>
</tr>
<tr>
<td valign="top" align="left">3</td>
<td valign="top" align="left">India</td>
<td valign="top" align="center">649</td>
<td valign="top" align="center">0.09</td>
<td valign="top" align="center">29</td>
</tr>
<tr>
<td valign="top" align="left">4</td>
<td valign="top" align="left">England</td>
<td valign="top" align="center">561</td>
<td valign="top" align="center">0.19</td>
<td valign="top" align="center">40</td>
</tr>
<tr>
<td valign="top" align="left">5</td>
<td valign="top" align="left">Turkey</td>
<td valign="top" align="center">458</td>
<td valign="top" align="center">0.00</td>
<td valign="top" align="center">27</td>
</tr>
<tr>
<td valign="top" align="left">6</td>
<td valign="top" align="left">Germany</td>
<td valign="top" align="center">371</td>
<td valign="top" align="center">0.08</td>
<td valign="top" align="center">35</td>
</tr>
<tr>
<td valign="top" align="left">7</td>
<td valign="top" align="left">Canada</td>
<td valign="top" align="center">329</td>
<td valign="top" align="center">0.04</td>
<td valign="top" align="center">35</td>
</tr>
<tr>
<td valign="top" align="left">8</td>
<td valign="top" align="left">Italy</td>
<td valign="top" align="center">313</td>
<td valign="top" align="center">0.03</td>
<td valign="top" align="center">29</td>
</tr>
<tr>
<td valign="top" align="left">9</td>
<td valign="top" align="left">Australia</td>
<td valign="top" align="center">267</td>
<td valign="top" align="center">0.07</td>
<td valign="top" align="center">32</td>
</tr>
<tr>
<td valign="top" align="left">10</td>
<td valign="top" align="left">Japan</td>
<td valign="top" align="center">238</td>
<td valign="top" align="center">0.00</td>
<td valign="top" align="center">25</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s3c"><label>3.3</label><title>Institutions</title>
<p><xref ref-type="fig" rid="F4">Figure&#x00A0;4</xref> displays the collaborative network graph for institutions, with the default settings of CiteSpace. Each institution&#x0027;s label and node represent the number of publications, and the connections between nodes indicate cooperative relationships. <xref ref-type="table" rid="T2">Table&#x00A0;2</xref> ranks the top 10 institutions by publication volume. The University of London, Harvard University, and the University of California System were the top three institutions in terms of publication output. The University of London and Harvard University shared the highest H-index of 37; all institutions in the top 7 had an H-index of 30 or higher. The top 10 institutions included six from the United States, three from England, and one from Egypt.</p>
<fig id="F4" position="float"><label>Figure 4</label>
<caption><p>Cooperation of institutions that contributed to publications on pediatric ophthalmopathy.</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fped-12-1405110-g004.tif"/>
</fig>
<table-wrap id="T2" position="float"><label>Table 2</label>
<caption><p>Top 10 institutions with publications on pediatric ophthalmopathy.</p></caption>
<table frame="hsides" rules="groups">
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="center"/>
<col align="center"/>
</colgroup>
<thead>
<tr>
<th valign="top" align="left">Rank</th>
<th valign="top" align="center">Institutions</th>
<th valign="top" align="center">Countries or regions</th>
<th valign="top" align="center">Counts</th>
<th valign="top" align="center">H-index</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">1</td>
<td valign="top" align="left">University of London</td>
<td valign="top" align="left">England</td>
<td valign="top" align="center">289</td>
<td valign="top" align="center">37</td>
</tr>
<tr>
<td valign="top" align="left">2</td>
<td valign="top" align="left">Harvard University</td>
<td valign="top" align="left">United States</td>
<td valign="top" align="center">265</td>
<td valign="top" align="center">37</td>
</tr>
<tr>
<td valign="top" align="left">3</td>
<td valign="top" align="left">University of California System</td>
<td valign="top" align="left">United States</td>
<td valign="top" align="center">257</td>
<td valign="top" align="center">31</td>
</tr>
<tr>
<td valign="top" align="left">4</td>
<td valign="top" align="left">University College London</td>
<td valign="top" align="left">England</td>
<td valign="top" align="center">215</td>
<td valign="top" align="center">34</td>
</tr>
<tr>
<td valign="top" align="left">5</td>
<td valign="top" align="left">University of Pennsylvania</td>
<td valign="top" align="left">United States</td>
<td valign="top" align="center">202</td>
<td valign="top" align="center">31</td>
</tr>
<tr>
<td valign="top" align="left">6</td>
<td valign="top" align="left">Pennsylvania Medicine</td>
<td valign="top" align="left">United States</td>
<td valign="top" align="center">183</td>
<td valign="top" align="center">31</td>
</tr>
<tr>
<td valign="top" align="left">7</td>
<td valign="top" align="left">Harvard Medical School</td>
<td valign="top" align="left">United States</td>
<td valign="top" align="center">179</td>
<td valign="top" align="center">31</td>
</tr>
<tr>
<td valign="top" align="left">8</td>
<td valign="top" align="left">Children&#x0027;s Hospital of Philadelphia</td>
<td valign="top" align="left">United States</td>
<td valign="top" align="center">158</td>
<td valign="top" align="center">28</td>
</tr>
<tr>
<td valign="top" align="left">9</td>
<td valign="top" align="left">Egyptian Knowledge Bank (EKB)</td>
<td valign="top" align="left">Egypt</td>
<td valign="top" align="center">140</td>
<td valign="top" align="center">19</td>
</tr>
<tr>
<td valign="top" align="left">10</td>
<td valign="top" align="left">Moorfields Eye Hospotal NHS Foundation Trust</td>
<td valign="top" align="left">England</td>
<td valign="top" align="center">139</td>
<td valign="top" align="center">27</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s3d"><label>3.4</label><title>Journals and research categories</title>
<p>Publications exhibit a citing-cited relationship, as do the journals themselves, with citing journals reflecting current research frontiers and cited journals representing the research foundation. <xref ref-type="table" rid="T3">Tables&#x00A0;3</xref>, <xref ref-type="table" rid="T4">4</xref> list the top 10 citing and cited journals, including journal names, research categories, citation counts, and the 2022 Journal Impact Factor. CiteSpace was utilized to visualize and analyze these relationships under default settings. The most prominent citing-cited relationship in research categories was neurology/sports/ophthalmology citing molecular/biology/genetics. The prevalent research categories in the top 10 citing and cited journals were ophthalmology, pediatrics, and science and technology.</p>
<table-wrap id="T3" position="float"><label>Table 3</label>
<caption><p>Top 10 citing journals of publications on pediatric ophthalmopathy.</p></caption>
<table frame="hsides" rules="groups">
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="center"/>
<col align="center"/>
</colgroup>
<thead>
<tr>
<th valign="top" align="left">Rank</th>
<th valign="top" align="center">Citing journals</th>
<th valign="top" align="center">Research categories</th>
<th valign="top" align="center">Counts</th>
<th valign="top" align="center">Journal impact factor 2022</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">1</td>
<td valign="top" align="left">Journal of AAPOS</td>
<td valign="top" align="left">Ophthalmology; Pediatrics</td>
<td valign="top" align="center">365</td>
<td valign="top" align="center">1.6</td>
</tr>
<tr>
<td valign="top" align="left">2</td>
<td valign="top" align="left">Indian Journal of Ophthalmology</td>
<td valign="top" align="left">Ophthalmology</td>
<td valign="top" align="center">258</td>
<td valign="top" align="center">3.1</td>
</tr>
<tr>
<td valign="top" align="left">3</td>
<td valign="top" align="left">PLoS One</td>
<td valign="top" align="left">Science &#x0026; Technology</td>
<td valign="top" align="center">181</td>
<td valign="top" align="center">3.7</td>
</tr>
<tr>
<td valign="top" align="left">4</td>
<td valign="top" align="left">BMC Ophthalmology</td>
<td valign="top" align="left">Ophthalmology</td>
<td valign="top" align="center">163</td>
<td valign="top" align="center">2.0</td>
</tr>
<tr>
<td valign="top" align="left">5</td>
<td valign="top" align="left">Investigative Ophthalmology &#x0026;Visual Science</td>
<td valign="top" align="left">Ophthalmology</td>
<td valign="top" align="center">159</td>
<td valign="top" align="center">4.4</td>
</tr>
<tr>
<td valign="top" align="left">6</td>
<td valign="top" align="left">American Journal of Ophthalmology</td>
<td valign="top" align="left">Ophthalmology</td>
<td valign="top" align="center">157</td>
<td valign="top" align="center">4.2</td>
</tr>
<tr>
<td valign="top" align="left">7</td>
<td valign="top" align="left">Scientific Reports</td>
<td valign="top" align="left">Science &#x0026; Technology</td>
<td valign="top" align="center">153</td>
<td valign="top" align="center">4.6</td>
</tr>
<tr>
<td valign="top" align="left">8</td>
<td valign="top" align="left">Journal of Pediatric Ophthalmology &#x0026;Strabismus</td>
<td valign="top" align="left">Ophthalmology; Pediatrics</td>
<td valign="top" align="center">151</td>
<td valign="top" align="center">1.2</td>
</tr>
<tr>
<td valign="top" align="left">9</td>
<td valign="top" align="left">Acta Ophthalmologica</td>
<td valign="top" align="left">Ophthalmology</td>
<td valign="top" align="center">143</td>
<td valign="top" align="center">3.4</td>
</tr>
<tr>
<td valign="top" align="left">10</td>
<td valign="top" align="left">European Journal of Ophthalmology</td>
<td valign="top" align="left">Ophthalmology</td>
<td valign="top" align="center">134</td>
<td valign="top" align="center">1.7</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="T4" position="float"><label>Table 4</label>
<caption><p>Top 10 cited journals of publications on pediatric ophthalmopathy.</p></caption>
<table frame="hsides" rules="groups">
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="center"/>
<col align="center"/>
</colgroup>
<thead>
<tr>
<th valign="top" align="left">Rank</th>
<th valign="top" align="center">Cited journals</th>
<th valign="top" align="center">Research categories</th>
<th valign="top" align="center">Counts</th>
<th valign="top" align="center">Journal impact factor 2022</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">1</td>
<td valign="top" align="left">Ophthalmology</td>
<td valign="top" align="left">Ophthalmology</td>
<td valign="top" align="center">3,933</td>
<td valign="top" align="center">13.7</td>
</tr>
<tr>
<td valign="top" align="left">2</td>
<td valign="top" align="left">British Journal of Ophthalmology</td>
<td valign="top" align="left">Ophthalmology</td>
<td valign="top" align="center">3,512</td>
<td valign="top" align="center">4.1</td>
</tr>
<tr>
<td valign="top" align="left">3</td>
<td valign="top" align="left">American Journal of Ophthalmology</td>
<td valign="top" align="left">Ophthalmology</td>
<td valign="top" align="center">3,162</td>
<td valign="top" align="center">4.2</td>
</tr>
<tr>
<td valign="top" align="left">4</td>
<td valign="top" align="left">Investigative Ophthalmology &#x0026; Visual Science</td>
<td valign="top" align="left">Ophthalmology</td>
<td valign="top" align="center">2,855</td>
<td valign="top" align="center">4.4</td>
</tr>
<tr>
<td valign="top" align="left">5</td>
<td valign="top" align="left">Journal of Aapos</td>
<td valign="top" align="left">Ophthalmology; Pediatrics</td>
<td valign="top" align="center">2,198</td>
<td valign="top" align="center">1.6</td>
</tr>
<tr>
<td valign="top" align="left">6</td>
<td valign="top" align="left">PLoS One</td>
<td valign="top" align="left">Science &#x0026; Technology</td>
<td valign="top" align="center">2,076</td>
<td valign="top" align="center">3.7</td>
</tr>
<tr>
<td valign="top" align="left">7</td>
<td valign="top" align="left">Eye</td>
<td valign="top" align="left">Ophthalmology</td>
<td valign="top" align="center">1,926</td>
<td valign="top" align="center">3.9</td>
</tr>
<tr>
<td valign="top" align="left">8</td>
<td valign="top" align="left">Pediatrics</td>
<td valign="top" align="left">Pediatrics</td>
<td valign="top" align="center">1,758</td>
<td valign="top" align="center">8.0</td>
</tr>
<tr>
<td valign="top" align="left">9</td>
<td valign="top" align="left">Acta Ophthalmologica</td>
<td valign="top" align="left">Ophthalmology</td>
<td valign="top" align="center">1,449</td>
<td valign="top" align="center">3.4</td>
</tr>
<tr>
<td valign="top" align="left">10</td>
<td valign="top" align="left">JAMA Ophthalmology</td>
<td valign="top" align="left">Ophthalmology</td>
<td valign="top" align="center">1,358</td>
<td valign="top" align="center">8.1</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s3e"><label>3.5</label><title>Authors</title>
<p><xref ref-type="fig" rid="F5">Figure&#x00A0;5</xref> depicts the authors of publications and collaborations in the field of pediatric ophthalmopathy, with the node area indicating the volume of publications, the pink outer circle of the node denoting the influence, and the connecting lines representing the collaborative network. <xref ref-type="table" rid="T5">Table&#x00A0;5</xref> exhibits information of the top 10 authors in terms of the number of publications, split into countries based on their institutions, with seven authors from the United States. The results reveal that Freedman,Sharon F was the most influential author with the highest number of publications in the field of pediatric ophthalmopathy.</p>
<fig id="F5" position="float"><label>Figure 5</label>
<caption><p>Cooperation of authors of publications on pediatric ophthalmopathy.</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fped-12-1405110-g005.tif"/>
</fig>
<table-wrap id="T5" position="float"><label>Table 5</label>
<caption><p>Top 10 authors of publications on pediatric ophthalmopathy.</p></caption>
<table frame="hsides" rules="groups">
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th valign="top" align="left">Rank</th>
<th valign="top" align="left">Authors</th>
<th valign="top" align="center">Counts</th>
<th valign="top" align="center">Centrality</th>
<th valign="top" align="center">H-index</th>
<th valign="top" align="left">Countries or regions</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">1</td>
<td valign="top" align="left">Freedman, Sharon F</td>
<td valign="top" align="center">55</td>
<td valign="top" align="center">0.01</td>
<td valign="top" align="center">19</td>
<td valign="top" align="left">United States</td>
</tr>
<tr>
<td valign="top" align="left">2</td>
<td valign="top" align="left">Binenbaum, Gil</td>
<td valign="top" align="center">42</td>
<td valign="top" align="center">0.01</td>
<td valign="top" align="center">16</td>
<td valign="top" align="left">United States</td>
</tr>
<tr>
<td valign="top" align="left">3</td>
<td valign="top" align="left">Hellstrom, Ann</td>
<td valign="top" align="center">21</td>
<td valign="top" align="center">0.09</td>
<td valign="top" align="center">12</td>
<td valign="top" align="left">Sweden</td>
</tr>
<tr>
<td valign="top" align="left">4</td>
<td valign="top" align="left">Quinn. Graham E</td>
<td valign="top" align="center">21</td>
<td valign="top" align="center">0.19</td>
<td valign="top" align="center">13</td>
<td valign="top" align="left">United States</td>
</tr>
<tr>
<td valign="top" align="left">5</td>
<td valign="top" align="left">Wu, Wei-Chi</td>
<td valign="top" align="center">21</td>
<td valign="top" align="center">0.00</td>
<td valign="top" align="center">11</td>
<td valign="top" align="left">China, Taiwan</td>
</tr>
<tr>
<td valign="top" align="left">6</td>
<td valign="top" align="left">Vanderveen, Deborah K</td>
<td valign="top" align="center">18</td>
<td valign="top" align="center">0.08</td>
<td valign="top" align="center">11</td>
<td valign="top" align="left">United States</td>
</tr>
<tr>
<td valign="top" align="left">7</td>
<td valign="top" align="left">Vinekar. Anand</td>
<td valign="top" align="center">16</td>
<td valign="top" align="center">0.02</td>
<td valign="top" align="center">9</td>
<td valign="top" align="left">India</td>
</tr>
<tr>
<td valign="top" align="left">8</td>
<td valign="top" align="left">Lambert, Scott R</td>
<td valign="top" align="center">15</td>
<td valign="top" align="center">0.02</td>
<td valign="top" align="center">11</td>
<td valign="top" align="left">United States</td>
</tr>
<tr>
<td valign="top" align="left">9</td>
<td valign="top" align="left">Shields, Carol L</td>
<td valign="top" align="center">15</td>
<td valign="top" align="center">0.00</td>
<td valign="top" align="center">7</td>
<td valign="top" align="left">United States</td>
</tr>
<tr>
<td valign="top" align="left">10</td>
<td valign="top" align="left">Ying, Gui-shuang</td>
<td valign="top" align="center">15</td>
<td valign="top" align="center">0.01</td>
<td valign="top" align="center">8</td>
<td valign="top" align="left">United States</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s3f"><label>3.6</label><title>Keywords</title>
<p>CiteSpace was employed to analyze co-occurring collaborative networks of keywords using the parameters: &#x201C;Year Per Slice&#x201D;&#x2009;&#x003D;&#x2009;1, &#x201C;Top N&#x0025;&#x201D;&#x2009;&#x003D;&#x2009;10.0&#x0025;, and &#x201C;Minimum Duration&#x201D;&#x2009;&#x003D;&#x2009;1. <xref ref-type="fig" rid="F6">Figure&#x00A0;6</xref> highlights the top 10 keywords with the strongest citation bursts, where strength indicates the intensity of the keyword&#x0027;s emergence. The red squares denote the timeline of keyword surges. &#x201C;Diabetic retinopathy&#x201D; and &#x201C;eye tracking&#x201D; were keywords with the longest periods of activity, while &#x201C;eye tracking,&#x201D; &#x201C;choroidal thickness,&#x201D; &#x201C;pediatric ophthalmology,&#x201D; &#x201C;impact,&#x201D; and &#x201C;childhood glaucoma&#x201D; were keywords that have emerged within the last three years.</p>
<fig id="F6" position="float"><label>Figure 6</label>
<caption><p>Keywords with the strongest citation bursts for publications on pediatric ophthalmopathy.</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fped-12-1405110-g006.tif"/>
</fig>
</sec>
<sec id="s3g"><label>3.7</label><title>High-impact publications</title>
<p>High-impact publications with high cited counts are indicative of well-regarded findings in pediatric ophthalmopathy, demonstrating the research hotspots in this field. <xref ref-type="table" rid="T6">Table&#x00A0;6</xref> lists the top 10 most highly cited publications in this field, covering aspects of pathogenesis, diagnosis, and treatment of ocular diseases in children. These articles predominantly featured clinical studies, particularly those focused on the treatment of retinopathy of prematurity, alongside mechanistic studies such as one exploring the metastatic pathway of retinoblastoma. The types of diseases were related to retinopathy of prematurity (4), myopia (2), retinoblastoma (1), uveitis in juvenile idiopathic arthritis (1), and ocular manifestations of systemic diseases (2).</p>
<table-wrap id="T6" position="float"><label>Table 6</label>
<caption><p>Publications with top ten citation on pediatric ophthalmopathy.</p></caption>
<table frame="hsides" rules="groups">
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="center"/>
<col align="center"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th valign="top" align="left">Rank</th>
<th valign="top" align="center">Title of publication</th>
<th valign="top" align="center">DOI</th>
<th valign="top" align="center">Times cited</th>
<th valign="top" align="center">Interpretation of the findings</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">1</td>
<td valign="top" align="left">Low-concentration atropine for myopia progression (LAMP) study A randomized, double-blinded, placebo-controlled trial of 0.05&#x0025;, 0.025&#x0025;, and 0.01&#x0025; atropine eye drops in myopia control (<xref ref-type="bibr" rid="B65">65</xref>)</td>
<td valign="top" align="center">10.1016/j.ophtha.2018.05.029</td>
<td valign="top" align="center">298</td>
<td valign="top" align="left">0.05&#x0025;, 0.025&#x0025;, and 0.01&#x0025; atropine eye drops slowed myopic progression in a concentration-dependent response. And 0.05&#x0025; atropine was most effective in controlling spherical equivalent progression and axial length elongation over 1 year.</td>
</tr>
<tr>
<td valign="top" align="left">2</td>
<td valign="top" align="left">Adalimumab plus methotrexate for uveitis in juvenile idiopathic arthritis (<xref ref-type="bibr" rid="B66">66</xref>)</td>
<td valign="top" align="center">10.1056/NEJMoa1614160</td>
<td valign="top" align="center">244</td>
<td valign="top" align="left">For uveitis in juvenile idiopathic arthritis, adalimumab in combination with methotrexate had a lower failure rate than placebo, but a higher rate of adverse events than placebo.</td>
</tr>
<tr>
<td valign="top" align="left">3</td>
<td valign="top" align="left">Neurodevelopmental outcomes following bevacizumab injections for retinopathy of prematurity (<xref ref-type="bibr" rid="B67">67</xref>)</td>
<td valign="top" align="center">10.1542/peds.2015-3218</td>
<td valign="top" align="center">206</td>
<td valign="top" align="left">Bevacizumab-treated versus laser-treated preterm infants with retinopathy have a higher incidence of severe neurodevelopmental disorders.</td>
</tr>
<tr>
<td valign="top" align="left">4</td>
<td valign="top" align="left">Ophthalmological findings in infants with microcephaly and presumable intra-uterus Zika virus infection (<xref ref-type="bibr" rid="B68">68</xref>)</td>
<td valign="top" align="center">10.5935/0004-2749.20160002</td>
<td valign="top" align="center">204</td>
<td valign="top" align="left">Infants with microcephalyhad a normal anterior segment and severe abnormalities in the macula and optic nerve.</td>
</tr>
<tr>
<td valign="top" align="left">5</td>
<td valign="top" align="left">Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial (<xref ref-type="bibr" rid="B69">69</xref>)</td>
<td valign="top" align="center">10.1016/S0140-6736(19)31344-3</td>
<td valign="top" align="center">198</td>
<td valign="top" align="left">For the treatment of retinopathy of prematurity, ranibizumab 0.2&#x2005;mg may be superior to laser therapy with fewer adverse local outcomes.</td>
</tr>
<tr>
<td valign="top" align="left">6</td>
<td valign="top" align="left">Eye tracking reveals abnormal visual preference for geometric images as an early biomarker of an autism spectrum disorder subtype associated with increased symptom severity (<xref ref-type="bibr" rid="B70">70</xref>)</td>
<td valign="top" align="center">10.1016/j.biopsych.2015.03.032</td>
<td valign="top" align="center">189</td>
<td valign="top" align="left">Enhanced visual preference for geometric repetition may be an early developmental biomarker of an ASD subtype with more severe symptoms.</td>
</tr>
<tr>
<td valign="top" align="left">7</td>
<td valign="top" align="left">Inhibition of MMP-2 and MMP-9 decreases cellular migration, and angiogenesis in in vitro models of retinoblastoma (<xref ref-type="bibr" rid="B71">71</xref>)</td>
<td valign="top" align="center">10.1186/s12885-017-3418-y</td>
<td valign="top" align="center">188</td>
<td valign="top" align="left">MMP-2 and MMP-9 drived the metastatic pathways of retinoblastoma, including migration, viability, and secretion of angiogenesis.</td>
</tr>
<tr>
<td valign="top" align="left">8</td>
<td valign="top" align="left">A dosing study of bevacizumab for retinopathy of prematurity late recurrences and additional treatments (<xref ref-type="bibr" rid="B72">72</xref>)</td>
<td valign="top" align="center">10.1016/j.ophtha.2018.05.001</td>
<td valign="top" align="center">178</td>
<td valign="top" align="left">Low-dose bevacizumab for retinopathy of prematurity had a very favorable outcome, but many eyes received other treatments.</td>
</tr>
<tr>
<td valign="top" align="left">9</td>
<td valign="top" align="left">Outcomes after intravitreal bevacizumab versus laser photocoagulation for retinopathy of prematurity a 5-year retrospective analysis (<xref ref-type="bibr" rid="B73">73</xref>)</td>
<td valign="top" align="center">10.1016/j.ophtha.2014.12.017</td>
<td valign="top" align="center">153</td>
<td valign="top" align="left">Intravitreal bevacizumab versus panretinal photocoagulation is an effective treatment option for retinopathy of type 1 prematurity, which has a low rate of myopia.</td>
</tr>
<tr>
<td valign="top" align="left">10</td>
<td valign="top" align="left">Effect of outdoor activity on myopia onset and progression in school-aged children in Northeast China: the Sujiatun eye care study (<xref ref-type="bibr" rid="B74">74</xref>)</td>
<td valign="top" align="center">10.1186/s12886-015-0052-9</td>
<td valign="top" align="center">151</td>
<td valign="top" align="left">Increased outdoor activity prevents the onset and progression of myopia in children, as well as axial growth and increased intraocular pressure.</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
</sec>
<sec id="s4" sec-type="discussion"><label>4</label><title>Discussion</title>
<sec id="s4a"><label>4.1</label><title>Overall data</title>
<p>Pediatric ophthalmopathy directly impair children&#x0027;s vision, affecting not only their health and quality of life but also their families and society, making pediatric ophthalmopathy a focal point for research. This study analyzed publications in the past decade from the WoSCC database to obtain research hotspots and trends in the field of pediatric ophthalmopathy. The analysis indicates that over the past decade, there has been a significant increase in pediatric ophthalmopathy research, particularly after 2021, with an annual publication count exceeding 1,000. In terms of national or regional contributions, the United States lead with the highest number of publications, centrality, and H-index, reflecting its dominant role in the field. China, ranking second in publication volume and H-index but with lower centrality, also exert significant influence, suggesting a need for enhanced international collaboration. England, despite having fewer publications, demonstrated high centrality and influence, indicating the value and collaborative nature of its research. Institutions such as the University of London and Harvard University stand out with the highest H-index, indicating their substantial impact. Freedman,Sharon F was the most authoritative author, and most of the authors with high posting volume and influence were from the United States. The journal research categories revealed a focus on pediatrics, ophthalmology, and science and technology, aiming to develop more effective diagnostic and treatment methods for pediatric ophthalmopathy. The analysis of burst keywords highlights the current research hotspots, and highly cited articles showcase impactful research findings, with retinopathy of prematurity, myopia, and retinoblastoma emerging as prominent areas of study. Specifically, four articles on retinopathy of prematurity were clinical studies assessing the efficacy and adverse effects of various treatments, including laser therapy, bevacizumab, and ranibizumab. These treatments showed potential clinical efficacy, but bevacizumab, when compared to laser therapy, was associated with a higher incidence of severe neurodevelopmental disorders, while ranibizumab therapy was found to be superior, with fewer adverse outcomes.</p>
</sec>
<sec id="s4b"><label>4.2</label><title>Research hotspots</title>
<p>The analysis of the publications on pediatric ophthalmopathy in the WoSCC database over the past 10 years provides access to the research hotspots in this field. Emerging burst keywords responds to the research hotspots. The evolving burst keywords across different time periods reflect the shifting research focus in pediatric ophthalmopathy. In 2014&#x2013;2016, the keyword &#x201C;family&#x201D; emerged, primarily encompassing family-related and genetically linked congenital eye diseases (<xref ref-type="bibr" rid="B18">18</xref>&#x2013;<xref ref-type="bibr" rid="B20">20</xref>), as well as aspects of family care (<xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B22">22</xref>). The keyword &#x201C;diabetic retinopathy&#x201D; gained prominence from 2015 to 2019, with a focus on early detection markers before clinical symptom onset, including retinal microcirculation changes (<xref ref-type="bibr" rid="B23">23</xref>), retinal nerve fiber layer thickness (<xref ref-type="bibr" rid="B24">24</xref>), choroidal thickness (<xref ref-type="bibr" rid="B25">25</xref>), and the integration of artificial intelligence methods (<xref ref-type="bibr" rid="B26">26</xref>). The keywords &#x201C;validation&#x201D; and &#x201C;survival&#x201D; emerged in 2019&#x2013;2020, with &#x201C;validation&#x201D; referring to the clinical validation of guidelines, standards, and questionnaires related to pediatric ophthalmopathy (<xref ref-type="bibr" rid="B27">27</xref>, <xref ref-type="bibr" rid="B28">28</xref>), and the capabilities of artificial intelligence platforms (<xref ref-type="bibr" rid="B29">29</xref>, <xref ref-type="bibr" rid="B30">30</xref>). Additionally, &#x201C;care&#x201D; became a significant keyword in 2020&#x2013;2021, highlighting the crucial role of care in pediatric ophthalmopathy (<xref ref-type="bibr" rid="B31">31</xref>, <xref ref-type="bibr" rid="B32">32</xref>). The keywords &#x201C;eye tracking&#x201D; and &#x201C;choroidal thickness&#x201D; emerged in 2020&#x2013;2023, followed by &#x201C;pediatric ophthalmology,&#x201D; &#x201C;impact,&#x201D; and &#x201C;childhood glaucoma&#x201D; in 2021&#x2013;2023, indicating the latest research trends in the field.</p>
<p>&#x201C;Eye tracking&#x201D; technology, which can automatically monitor the visual dynamics of young children, has been applied in screening for autism spectrum disorder (<xref ref-type="bibr" rid="B33">33</xref>, <xref ref-type="bibr" rid="B34">34</xref>), detecting glaucoma (<xref ref-type="bibr" rid="B35">35</xref>), quantifying the severity of intermittent esotropia (<xref ref-type="bibr" rid="B36">36</xref>), and assessing vision in infants and children (<xref ref-type="bibr" rid="B37">37</xref>). Ahmed et al. developed three AI techniques for early autism diagnosis using eye-tracking data, all achieving over 90&#x0025; accuracy (<xref ref-type="bibr" rid="B38">38</xref>). Wen et al. proposed an automated acuity card procedure based on eye-tracking technology for assessing children&#x0027;s visual acuity, with results comparable to Teller Acuity Cards (<xref ref-type="bibr" rid="B37">37</xref>).</p>
<p>&#x201C;Choroidal thickness&#x201D; emerged as a keyword with significant intensity, serving as a critical indicator for assessing myopia development in children (<xref ref-type="bibr" rid="B39">39</xref>, <xref ref-type="bibr" rid="B40">40</xref>). Zhu et al. found a positive correlation between the degree of myopia in children and choroidal thickness using Pearson correlation analysis (<xref ref-type="bibr" rid="B41">41</xref>). Jiang et al. discovered that choroidal thickness thinning in myopic patients was more pronounced nasally than temporally and superiorly, suggesting that asymmetric nasal predominance of thinning choroidal thickness could be a new biomarker for early-onset high myopia (<xref ref-type="bibr" rid="B42">42</xref>). Monitoring choroidal thickness may thus provide valuable insights, aligning with the high citation of articles focusing on myopia as the predominant disorder.</p>
<p>&#x201C;Pediatric ophthalmology,&#x201D; the dominant burst keyword from 2021 to 2023, signifies a growing interest in the field as a whole, with an increasing number of studies focusing on pediatric ophthalmology in general (<xref ref-type="bibr" rid="B43">43</xref>), rather than solely on children, pediatrics, or specific diseases. Ramsay et al. conducted a retrospective analysis of the epidemiology and diagnosis of pediatric ocular diseases in ophthalmology emergencies, summarizing patterns of pediatric ophthalmology consultations in such situations (<xref ref-type="bibr" rid="B44">44</xref>). As a subspecialty, this keyword also encompasses the development of pediatric ophthalmology, its economic and social impact (<xref ref-type="bibr" rid="B45">45</xref>&#x2013;<xref ref-type="bibr" rid="B47">47</xref>), and the impact of economic factors, such as recessions, on the field and eye care (<xref ref-type="bibr" rid="B48">48</xref>).</p>
<p>The keyword &#x201C;impact&#x201D; addresses the effects of treatments and social factors on pediatric ophthalmopathy, as well as the repercussions of these conditions on family life and psychological well-being. Luccarelli et al. investigated the efficacy of oral acyclovir in preventing herpetic keratitis recurrences, demonstrating its safety and effectiveness (<xref ref-type="bibr" rid="B49">49</xref>). Shah et al. explored the impact of COVID-19 on pediatric ophthalmology emergency services, noting a decline in attendance (<xref ref-type="bibr" rid="B50">50</xref>). da Silva et al. assessed the psychosocial implications of surgical treatment for primary congenital glaucoma on children and their families (<xref ref-type="bibr" rid="B51">51</xref>).</p>
<p>&#x201C;Childhood glaucoma,&#x201D; a prevalent research topic, is characterized by a persistent increase in intraocular pressure, potentially leading to blindness. Surgical treatments for childhood glaucoma are a significant research area, encompassing procedures such as trabeculotomy (<xref ref-type="bibr" rid="B52">52</xref>), combined trabeculotomy-trabeculectomy (<xref ref-type="bibr" rid="B53">53</xref>), angio-atriotomy (<xref ref-type="bibr" rid="B54">54</xref>), Ahmed glaucoma drainage device implantation (<xref ref-type="bibr" rid="B55">55</xref>, <xref ref-type="bibr" rid="B56">56</xref>), Baerveldt glaucoma drainage device implantation (<xref ref-type="bibr" rid="B57">57</xref>), ciliary body photocoagulation (<xref ref-type="bibr" rid="B58">58</xref>), and XEN gel stent implantation (<xref ref-type="bibr" rid="B59">59</xref>), as well as penetrating otoplasty for refractory cases (<xref ref-type="bibr" rid="B60">60</xref>). Visual outcomes have been correlated with factors such as age at diagnosis, corneal clouding, and the presence of concurrent amblyopia (<xref ref-type="bibr" rid="B61">61</xref>, <xref ref-type="bibr" rid="B62">62</xref>). Recent research has also identified associations with genetic mutations (<xref ref-type="bibr" rid="B63">63</xref>, <xref ref-type="bibr" rid="B64">64</xref>).</p>
</sec>
<sec id="s4c"><label>4.3</label><title>Trends discussion</title>
<p>The increasing number of publications in pediatric ophthalmopathy represents that this field is in a research hotspot. The emerging burst keywords and high-impact publications in recent years represent the changing trends in the field of pediatric ophthalmopathy. Myopia, childhood glaucoma, retinopathy of prematurity, retinoblastoma and uveitis in juvenile idiopathic arthritis are the hot diseases in research, and modern technology such as eye tracking has become a popular application technology for the diagnosis and intervention of pediatric ophthalmopathy, and the current research has focused more on the overall relationship between pediatric ophthalmopathy and social factors. These hot diseases, hot technologies, and holistic research are the research trends in the field of pediatric ophthalmopathy, which can inform clinical practice and will also become the directions of future research, and further improve eye health in children.</p>
</sec>
<sec id="s4d"><label>4.4</label><title>Limitations and resolvents</title>
<p>This study acknowledges several limitations that may affect the comprehensiveness and generalizability of the findings. Firstly, in order to high-quality articles, the publication selection was constrained by the use of the Web of Science Core Collection (WoSCC) database exclusively, which may have resulted in an incomplete collection of relevant literature. Utilizing multiple databases could have provided a more comprehensive view. Secondly, the search was restricted to English-language articles, potentially excluding valuable research from other linguistic domains. Thirdly, the document type was also limited to article, which may have omitted important contributions from other formats such as conference proceedings or reviews. And, some research results were not published in publications. And time constraints have been imposed to obtain hotspots for new timelines, which may lead to incomplete literature coverage. Additionally, the research content of the selected publications presents certain limitations. In clinical studies on medications, treatments, and pathogenesis of pediatric ophthalmopathy, the sample sizes are small, necessitating larger samples and cross-regional studies for more robust findings. The application of artificial intelligence in pediatric ophthalmopathy, while a growing area of scientific research, lacks sufficient clinical application studies and consistent models, which could hinder its practical implementation. The integration of resources to facilitate clinical research in this area is needed. Furthermore, the understanding of the underlying mechanisms of pediatric ophthalmopathy remains limited, indicating a need for more in-depth research in this domain.</p>
</sec>
</sec>
<sec id="s5" sec-type="conclusions"><label>5</label><title>Conclusion</title>
<p>This study offers a systematic bibliometric and visualized analysis of pediatric ophthalmopathy research over the past decade, providing a comprehensive overview of the field&#x0027;s current status and research hotspots. The study reveals a growing global interest in pediatric ophthalmopathy, particularly post-2021, with the United States and China exerting the most significant influence. Prominent institutions include the University of London and Stanford University, and Freedman,Sharon F was the most prominent. The primary research categories encompass pediatrics, ophthalmology, and science and technology, with a focus on diseases such as diabetic retinopathy, childhood glaucoma, retinopathy of prematurity, and myopia. Key areas of interest include &#x201C;eye tracking,&#x201D; &#x201C;choroidal thickness,&#x201D; &#x201C;pediatric ophthalmology,&#x201D; &#x201C;impact,&#x201D; and &#x201C;childhood glaucoma.&#x201D;</p>
<p>In summary, the study highlights ongoing in-depth research into the pathogenesis, screening, prevention, and treatment of pediatric ophthalmopathy. The integration of modern science and technology, such as eye tracking and deep learning, may offer more reliable methods for assessing and diagnosing these conditions. Further investigation into choroidal thickness could yield novel biological markers for myopia severity. Additionally, there is a growing emphasis on understanding the impact of childhood eye diseases on families and society. Given that ocular abnormalities in children can lead to irreversible vision damage and adverse effects on children eye health, early diagnosis and treatment are crucial for the prognosis of children&#x0027;s vision. Current research in pediatric ophthalmopathy primarily focuses on etiology, diagnosis, and treatment. However, there is a need for extensive research into the genetics and molecular mechanisms of pediatric ophthalmopathy to provide a more comprehensive and effective foundation for clinical practice.</p>
</sec>
</body>
<back>
<sec id="s6" sec-type="data-availability"><title>Data availability statement</title>
<p>Publicly available datasets were analyzed in this study. This data can be found here: <ext-link ext-link-type="uri" xlink:href="https://www.webofscience.com/">https://www.webofscience.com/</ext-link>.</p>
</sec>
<sec id="s7" sec-type="author-contributions"><title>Author contributions</title>
<p>QJ: Conceptualization, Data curation, Formal Analysis, Writing &#x2013; original draft. XW: Data curation, Formal Analysis, Software, Visualization, Writing &#x2013; original draft. XL: Formal Analysis, Software, Validation, Writing &#x2013; original draft. CX: Methodology, Software, Visualization, Writing &#x2013; original draft. QZ: Software, Visualization, Writing &#x2013; original draft. JM: Funding acquisition, Methodology, Supervision, Visualization, Writing &#x2013; review &#x0026; editing. WY: Conceptualization, Methodology, Project administration, Resources, Writing &#x2013; review &#x0026; editing.</p>
</sec>
<sec id="s8" sec-type="funding-information"><title>Funding</title>
<p>The author(s) declare financial support was received for the research, authorship, and/or publication of this article.</p>
<p>This study was supported by Shenzhen Fund for Guangdong Provincial High-level Clinical Key Specialties (SZGSP014), Sanming Project of Medicine in Shenzhen (SZSM202311012) and Shenzhen Science and Technology Program (JCYJ20230807114608016).</p>
</sec>
<sec id="s9" sec-type="COI-statement"><title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s10" sec-type="disclaimer"><title>Publisher&#x0027;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list><title>References</title>
<ref id="B1"><label>1.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bourke</surname><given-names>CM</given-names></name><name><surname>Loughman</surname><given-names>J</given-names></name><name><surname>Flitcroft</surname><given-names>D</given-names></name><name><surname>Loskutova</surname><given-names>E</given-names></name><name><surname>O&#x2019;Brien</surname><given-names>C</given-names></name></person-group>. <article-title>We can&#x2019;t afford to turn a blind eye to myopia</article-title>. <source>QJM- Int J Med</source>. (<year>2023</year>) <volume>116</volume>(<issue>8</issue>):<fpage>635</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1093/qjmed/hcz076</pub-id></citation></ref>
<ref id="B2"><label>2.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>YC</given-names></name><name><surname>Hsu</surname><given-names>NW</given-names></name><name><surname>Wang</surname><given-names>CY</given-names></name><name><surname>Shyong</surname><given-names>MP</given-names></name><name><surname>Tsai</surname><given-names>DC</given-names></name></person-group>. <article-title>Prevalence trend of myopia after promoting eye care in preschoolers A serial survey in Taiwan before and during the coronavirus disease 2019 pandemic</article-title>. <source>Ophthalmology</source>. (<year>2022</year>) <volume>129</volume>(<issue>2</issue>):<fpage>181</fpage>&#x2013;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1016/j.ophtha.2021.08.013</pub-id><pub-id pub-id-type="pmid">34425129</pub-id></citation></ref>
<ref id="B3"><label>3.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>SF</given-names></name><name><surname>Li</surname><given-names>SM</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Kang</surname><given-names>MT</given-names></name><name><surname>Sun</surname><given-names>YY</given-names></name><etal/></person-group> <article-title>Sleep duration, bedtime, and myopia progression in a 4-year follow-up of Chinese children: the Anyang childhood eye study</article-title>. <source>Invest Ophthalmol Vis Sci</source>. (<year>2020</year>) <volume>61</volume>(<issue>3</issue>):<fpage>37</fpage>. <pub-id pub-id-type="doi">10.1167/iovs.61.3.37</pub-id></citation></ref>
<ref id="B4"><label>4.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sen</surname><given-names>P</given-names></name><name><surname>Wu</surname><given-names>WC</given-names></name><name><surname>Chandra</surname><given-names>P</given-names></name><name><surname>Vinekar</surname><given-names>A</given-names></name><name><surname>Manchegowda</surname><given-names>PT</given-names></name><name><surname>Bhende</surname><given-names>P</given-names></name></person-group>. <article-title>Retinopathy of prematurity treatment: Asian perspectives</article-title>. <source>Eye</source>. (<year>2020</year>) <volume>34</volume>(<issue>4</issue>):<fpage>632</fpage>&#x2013;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1038/s41433-019-0643-4</pub-id><pub-id pub-id-type="pmid">31664193</pub-id></citation></ref>
<ref id="B5"><label>5.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dai</surname><given-names>C</given-names></name><name><surname>Webster</surname><given-names>KA</given-names></name><name><surname>Bhatt</surname><given-names>A</given-names></name><name><surname>Tian</surname><given-names>H</given-names></name><name><surname>Su</surname><given-names>G</given-names></name><name><surname>Li</surname><given-names>W</given-names></name></person-group>. <article-title>Concurrent physiological and pathological angiogenesis in retinopathy of prematurity and emerging therapies</article-title>. <source>Int J Mol Sci</source>. (<year>2021</year>) <volume>22</volume>(<issue>9</issue>):<fpage>4809</fpage>. <pub-id pub-id-type="doi">10.3390/ijms22094809</pub-id><pub-id pub-id-type="pmid">34062733</pub-id></citation></ref>
<ref id="B6"><label>6.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tam</surname><given-names>EK</given-names></name><name><surname>Elhusseiny</surname><given-names>AM</given-names></name><name><surname>Shah</surname><given-names>AS</given-names></name><name><surname>Mantagos</surname><given-names>IS</given-names></name><name><surname>VanderVeen</surname><given-names>DK</given-names></name></person-group>. <article-title>Etiology and outcomes of childhood glaucoma at a tertiary referral center</article-title>. <source>J AAPOS</source>. (<year>2022</year>) <volume>26</volume>(<issue>3</issue>) <fpage>117.e1</fpage>&#x2013;<lpage>e6</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaapos.2021.12.009</pub-id><pub-id pub-id-type="pmid">35398512</pub-id></citation></ref>
<ref id="B7"><label>7.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baig</surname><given-names>NB</given-names></name><name><surname>Chan</surname><given-names>JJ</given-names></name><name><surname>Ho</surname><given-names>JC</given-names></name><name><surname>Tang</surname><given-names>GC</given-names></name><name><surname>Tsang</surname><given-names>S</given-names></name><name><surname>Wan</surname><given-names>KH</given-names></name><etal/></person-group> <article-title>Paediatric glaucoma in Hong Kong: a multicentre retrospective analysis of epidemiology, presentation, clinical interventions, and outcomes</article-title>. <source>Hong Kong Med J</source>. (<year>2021</year>) <volume>27</volume>(<issue>1</issue>):<fpage>18</fpage>&#x2013;<lpage>26</lpage>. <pub-id pub-id-type="doi">10.12809/hkmj208833</pub-id><pub-id pub-id-type="pmid">33542158</pub-id></citation></ref>
<ref id="B8"><label>8.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>WH</given-names></name><name><surname>Shao</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>YW</given-names></name></person-group>, <collab>Expert Workgroup of Guidelines on Clinical Research Evaluation of Artificial Intelligence in Ophthalmology (2023)</collab>, <collab>Ophthalmic Imaging and Intelligent Medicine Branch of Chinese Medicine Education Association</collab>, <collab>Intelligent Medicine Committee of Chinese Medicine Education Association</collab>. <article-title>Guidelines on clinical research evaluation of artificial intelligence in ophthalmology (2023)</article-title>. <source>Int J Ophthalmol</source>. (<year>2023</year>) <volume>16</volume>(<issue>9</issue>):<fpage>1361</fpage>&#x2013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.18240/ijo.2023.09.02</pub-id><pub-id pub-id-type="pmid">37724285</pub-id></citation></ref>
<ref id="B9"><label>9.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>S</given-names></name><name><surname>Zhan</surname><given-names>H</given-names></name><name><surname>Yan</surname><given-names>Z</given-names></name><name><surname>Wu</surname><given-names>M</given-names></name><name><surname>Zheng</surname><given-names>B</given-names></name><name><surname>Xu</surname><given-names>S</given-names></name><etal/></person-group> <article-title>Prediction of spherical equivalent refraction and axial length in children based on machine learning</article-title>. <source>Indian J Ophthalmol</source>. (<year>2023</year>) <volume>71</volume>(<issue>5</issue>):<fpage>2115</fpage>&#x2013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.4103/IJO.IJO_2989_22</pub-id><pub-id pub-id-type="pmid">37203092</pub-id></citation></ref>
<ref id="B10"><label>10.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cuocolo</surname><given-names>R</given-names></name><name><surname>Ponsiglione</surname><given-names>A</given-names></name><name><surname>Dell&#x2019;Aversana</surname><given-names>S</given-names></name><name><surname>D&#x2019;Acierno</surname><given-names>L</given-names></name><name><surname>Lassandro</surname><given-names>G</given-names></name><name><surname>Ugga</surname><given-names>L</given-names></name><etal/></person-group> <article-title>The cardiac conundrum: a systematic review and bibliometric analysis of authorship in cardiac magnetic resonance imaging studies</article-title>. <source>Insights Imaging</source>. (<year>2020</year>) <volume>11</volume>(<issue>1</issue>):<fpage>42</fpage>. <pub-id pub-id-type="doi">10.1186/s13244-020-00850-1</pub-id><pub-id pub-id-type="pmid">32107649</pub-id></citation></ref>
<ref id="B11"><label>11.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>R</given-names></name><name><surname>Zuo</surname><given-names>G</given-names></name><name><surname>Li</surname><given-names>K</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Xuan</surname><given-names>Z</given-names></name><name><surname>Han</surname><given-names>Y</given-names></name><etal/></person-group> <article-title>Systematic bibliometric and visualized analysis of research hotspots and trends on the application of artificial intelligence in diabetic retinopathy</article-title>. <source>Front Endocrinol</source>. (<year>2022</year>) <volume>13</volume>:<fpage>1036426</fpage>. <pub-id pub-id-type="doi">10.3389/fendo.2022.1036426</pub-id></citation></ref>
<ref id="B12"><label>12.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Lou</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Yang</surname><given-names>W</given-names></name></person-group>. <article-title>A bibliometric analysis of artificial intelligence applications in macular edema: exploring research hotspots and frontiers</article-title>. <source>Front Cell Dev Biol</source>. (<year>2023</year>) <volume>11</volume>:<fpage>1174936</fpage>. <pub-id pub-id-type="doi">10.3389/fcell.2023.1174936</pub-id><pub-id pub-id-type="pmid">37255600</pub-id></citation></ref>
<ref id="B13"><label>13.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jain</surname><given-names>D</given-names></name><name><surname>Dhua</surname><given-names>AK</given-names></name></person-group>. <article-title>Bibliometric analysis of pediatric glaucoma</article-title>. <source>Indian J Ophthalmol</source>. (<year>2023</year>) <volume>71</volume>(<issue>5</issue>):<fpage>2152</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.4103/IJO.IJO_2998_22</pub-id><pub-id pub-id-type="pmid">37203096</pub-id></citation></ref>
<ref id="B14"><label>14.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Yang</surname><given-names>W</given-names></name><name><surname>Lv</surname><given-names>H</given-names></name><name><surname>Huang</surname><given-names>L</given-names></name><name><surname>Yao</surname><given-names>T</given-names></name><name><surname>He</surname><given-names>Y</given-names></name></person-group>. <article-title>The top 100 most cited manuscripts in retinopathy of prematurity: a bibliometric analysis</article-title>. <source>Semin Ophthalmol</source>. (<year>2023</year>) <volume>38</volume>(<issue>3</issue>):<fpage>306</fpage>&#x2013;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1080/08820538.2023.2177115</pub-id><pub-id pub-id-type="pmid">36843278</pub-id></citation></ref>
<ref id="B15"><label>15.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>X</given-names></name><name><surname>Xie</surname><given-names>M</given-names></name><name><surname>Jia</surname><given-names>R</given-names></name><name><surname>Ge</surname><given-names>S</given-names></name></person-group>. <article-title>Publication trends of research on retinoblastoma during 2001&#x2013;2021: a 20-year bibliometric analysis</article-title>. <source>Front Med</source>. (<year>2021</year>) <volume>8</volume>:<fpage>675703</fpage>. <pub-id pub-id-type="doi">10.3389/fmed.2021.675703</pub-id></citation></ref>
<ref id="B16"><label>16.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Birkle</surname><given-names>C</given-names></name><name><surname>Pendlebury</surname><given-names>DA</given-names></name><name><surname>Schnell</surname><given-names>J</given-names></name><name><surname>Adams</surname><given-names>J</given-names></name></person-group>. <article-title>Web of science as a data source for research on scientific and scholarly activity</article-title>. <source>Quant Sci Stud</source>. (<year>2020</year>) <volume>1</volume>(<issue>1</issue>):<fpage>363</fpage>&#x2013;<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1162/qss_a_00018</pub-id></citation></ref>
<ref id="B17"><label>17.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>VK</given-names></name><name><surname>Singh</surname><given-names>P</given-names></name><name><surname>Karmakar</surname><given-names>M</given-names></name><name><surname>Leta</surname><given-names>J</given-names></name><name><surname>Mayr</surname><given-names>P</given-names></name></person-group>. <article-title>The journal coverage of web of science, scopus and dimensions: a comparative analysis</article-title>. <source>Scientometrics</source>. (<year>2021</year>) <volume>126</volume>:<fpage>5113</fpage>&#x2013;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1007/s11192-021-03948-5</pub-id></citation></ref>
<ref id="B18"><label>18.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cardoso</surname><given-names>MS</given-names></name><name><surname>Anjos</surname><given-names>R</given-names></name><name><surname>Vieira</surname><given-names>L</given-names></name><name><surname>Ferreira</surname><given-names>C</given-names></name><name><surname>Xavier</surname><given-names>A</given-names></name><name><surname>Brito</surname><given-names>C</given-names></name></person-group>. <article-title>CYP1B1 gene analysis and phenotypic correlation in Portuguese children with primary congenital glaucoma</article-title>. <source>Eur J Ophthalmol</source>. (<year>2015</year>) <volume>25</volume>(<issue>6</issue>):<fpage>474</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.5301/ejo.5000618</pub-id><pub-id pub-id-type="pmid">25952714</pub-id></citation></ref>
<ref id="B19"><label>19.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Gao</surname><given-names>F</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name></person-group>. <article-title>Whole-exome sequencing reveals a novel CHM gene mutation in a family with choroideremia initially diagnosed as retinitis pigmentosa</article-title>. <source>BMC Ophthalmol</source>. (<year>2015</year>) <volume>15</volume>:<fpage>85</fpage>. <pub-id pub-id-type="doi">10.1186/s12886-015-0081-4</pub-id><pub-id pub-id-type="pmid">26216097</pub-id></citation></ref>
<ref id="B20"><label>20.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Branham</surname><given-names>K</given-names></name><name><surname>Matsui</surname><given-names>H</given-names></name><name><surname>Biswas</surname><given-names>P</given-names></name><name><surname>Guru</surname><given-names>AA</given-names></name><name><surname>Hicks</surname><given-names>M</given-names></name><name><surname>Suk</surname><given-names>JJ</given-names></name><etal/></person-group> <article-title>Establishing the involvement of the novel gene AGBL5 in retinitis pigmentosa by whole genome sequencing</article-title>. <source>Physiol Genomics</source>. (<year>2016</year>) <volume>48</volume>(<issue>12</issue>):<fpage>922</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1152/physiolgenomics.00101.2016</pub-id><pub-id pub-id-type="pmid">27764769</pub-id></citation></ref>
<ref id="B21"><label>21.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>LJ</given-names></name><name><surname>Zhong</surname><given-names>WX</given-names></name><name><surname>Ji</surname><given-names>XD</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name></person-group>. <article-title>Depression, caregiver burden and social support among caregivers of retinoblastoma patients in China</article-title>. <source>Int J Nurs Pract</source>. (<year>2016</year>) <volume>22</volume>(<issue>5</issue>):<fpage>478</fpage>&#x2013;<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1111/ijn.12458</pub-id><pub-id pub-id-type="pmid">27325472</pub-id></citation></ref>
<ref id="B22"><label>22.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Donaldson</surname><given-names>L</given-names></name><name><surname>Subramanian</surname><given-names>A</given-names></name><name><surname>Conway</surname><given-names>ML</given-names></name></person-group>. <article-title>Eye care in young children: a parent survey exploring access and barriers</article-title>. <source>Clin Exp Optom</source>. (<year>2018</year>) <volume>101</volume>(<issue>4</issue>):<fpage>521</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1111/cxo.12683</pub-id><pub-id pub-id-type="pmid">29635865</pub-id></citation></ref>
<ref id="B23"><label>23.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Inanc</surname><given-names>M</given-names></name><name><surname>Tekin</surname><given-names>K</given-names></name><name><surname>Kiziltoprak</surname><given-names>H</given-names></name><name><surname>Ozalkak</surname><given-names>S</given-names></name><name><surname>Doguizi</surname><given-names>S</given-names></name><name><surname>Aycan</surname><given-names>Z</given-names></name></person-group>. <article-title>Changes in retinal microcirculation precede the clinical onset of diabetic retinopathy in children with type 1 diabetes Mellitus</article-title>. <source>Am J Ophthalmol</source>. (<year>2019</year>) <volume>207</volume>:<fpage>37</fpage>&#x2013;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajo.2019.04.011</pub-id><pub-id pub-id-type="pmid">31009594</pub-id></citation></ref>
<ref id="B24"><label>24.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tekin</surname><given-names>K</given-names></name><name><surname>Inanc</surname><given-names>M</given-names></name><name><surname>Kurnaz</surname><given-names>E</given-names></name><name><surname>Bayramoglu</surname><given-names>E</given-names></name><name><surname>Aydemir</surname><given-names>E</given-names></name><name><surname>Koc</surname><given-names>M</given-names></name><etal/></person-group> <article-title>Quantitative evaluation of early retinal changes in children with type 1 diabetes mellitus without retinopathy</article-title>. <source>Clin Exp Optom</source>. (<year>2018</year>) <volume>101</volume>(<issue>5</issue>):<fpage>680</fpage>&#x2013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1111/cxo.12667</pub-id><pub-id pub-id-type="pmid">29488254</pub-id></citation></ref>
<ref id="B25"><label>25.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Golebiewska</surname><given-names>J</given-names></name><name><surname>Olechowski</surname><given-names>A</given-names></name><name><surname>Wysocka-Mincewicz</surname><given-names>M</given-names></name><name><surname>Baszynska-Wilk</surname><given-names>M</given-names></name><name><surname>Groszek</surname><given-names>A</given-names></name><name><surname>Czeszyk-Piotrowicz</surname><given-names>A</given-names></name><etal/></person-group> <article-title>Choroidal thickness and ganglion cell Complex in pubescent children with type 1 diabetes without diabetic retinopathy analyzed by spectral domain optical coherence tomography</article-title>. <source>J Diabetes Res</source>. (<year>2018</year>) <volume>2018</volume>:<fpage>5458015</fpage>. <pub-id pub-id-type="doi">10.1155/2018/5458015</pub-id><pub-id pub-id-type="pmid">29850607</pub-id></citation></ref>
<ref id="B26"><label>26.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Memari</surname><given-names>N</given-names></name><name><surname>Ramli</surname><given-names>AR</given-names></name><name><surname>Bin Saripan</surname><given-names>MI</given-names></name><name><surname>Mashohor</surname><given-names>S</given-names></name><name><surname>Moghbel</surname><given-names>M</given-names></name></person-group>. <article-title>Retinal blood vessel segmentation by using matched filtering and fuzzy C-means clustering with integrated level set method for diabetic retinopathy assessment</article-title>. <source>J Med Biol Eng</source>. (<year>2019</year>) <volume>39</volume>(<issue>5</issue>):<fpage>713</fpage>&#x2013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1007/s40846-018-0454-2</pub-id></citation></ref>
<ref id="B27"><label>27.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Foeldvari</surname><given-names>I</given-names></name><name><surname>Klotsche</surname><given-names>J</given-names></name><name><surname>Simonini</surname><given-names>G</given-names></name><name><surname>Edelsten</surname><given-names>C</given-names></name><name><surname>Angeles-Han</surname><given-names>ST</given-names></name><name><surname>Bangsgaard</surname><given-names>R</given-names></name><etal/></person-group> <article-title>Proposal for a definition for response to treatment, inactive disease and damage for JIA associated uveitis based on the validation of a uveitis related JIA outcome measures from the multinational interdisciplinary working group for uveitis in childhood (MIWGUC)</article-title>. <source>Pediatr Rheumatol</source>. (<year>2019</year>) <volume>17</volume>(<issue>1</issue>):<fpage>66</fpage>. <pub-id pub-id-type="doi">10.1186/s12969-019-0345-2</pub-id></citation></ref>
<ref id="B28"><label>28.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Caruggi</surname><given-names>S</given-names></name><name><surname>Scaramuzzi</surname><given-names>M</given-names></name><name><surname>Calevo</surname><given-names>MG</given-names></name><name><surname>Priolo</surname><given-names>E</given-names></name><name><surname>Sposetti</surname><given-names>L</given-names></name><name><surname>Camicione</surname><given-names>P</given-names></name><etal/></person-group> <article-title>Validation of the postnatal growth and retinopathy of prematurity screening criteria: a retrospective Italian analysis</article-title>. <source>Eur J Ophthalmol</source>. (<year>2022</year>) <volume>32</volume>(<issue>2</issue>):<fpage>1169</fpage>&#x2013;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1177/11206721211011362</pub-id></citation></ref>
<ref id="B29"><label>29.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>R</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><etal/></person-group> <article-title>Diagnostic efficacy and therapeutic decision-making capacity of an artificial intelligence platform for childhood cataracts in eye clinics: a multicentre randomized controlled trial</article-title>. <source>EclinicalMedicine</source>. (<year>2019</year>) <volume>9</volume>:<fpage>52</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.eclinm.2019.03.001</pub-id><pub-id pub-id-type="pmid">31143882</pub-id></citation></ref>
<ref id="B30"><label>30.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tong</surname><given-names>Y</given-names></name><name><surname>Lu</surname><given-names>W</given-names></name><name><surname>Deng</surname><given-names>QQ</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Shen</surname><given-names>Y</given-names></name></person-group>. <article-title>Automated identification of retinopathy of prematurity by image-based deep learning</article-title>. <source>EYE Vis</source>. (<year>2020</year>) <volume>7</volume>(<issue>1</issue>):<fpage>40</fpage>. <pub-id pub-id-type="doi">10.1186/s40662-020-00206-2</pub-id></citation></ref>
<ref id="B31"><label>31.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sachan</surname><given-names>A</given-names></name><name><surname>Chandra</surname><given-names>P</given-names></name><name><surname>Agarwal</surname><given-names>R</given-names></name><name><surname>Vohra</surname><given-names>R</given-names></name><name><surname>Chawla</surname><given-names>R</given-names></name><name><surname>Sankar</surname><given-names>MJ</given-names></name><etal/></person-group> <article-title>Profile of retinopathy of prematurity in outborn and inborn babies at a tertiary eye care hospital</article-title>. <source>Indian Pediatr</source>. (<year>2020</year>) <volume>57</volume>(<issue>11</issue>):<fpage>1020</fpage>&#x2013;<lpage>2</lpage>. <pub-id pub-id-type="doi">10.1007/s13312-020-2027-z</pub-id><pub-id pub-id-type="pmid">32533682</pub-id></citation></ref>
<ref id="B32"><label>32.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yousef</surname><given-names>YA</given-names></name><name><surname>Al-Nawaiseh</surname><given-names>I</given-names></name><name><surname>Mehyar</surname><given-names>M</given-names></name><name><surname>Sultan</surname><given-names>I</given-names></name><name><surname>Al-Hussaini</surname><given-names>M</given-names></name><name><surname>Jaradat</surname><given-names>I</given-names></name><etal/></person-group> <article-title>How telemedicine and centralized care changed the natural history of retinoblastoma in a developing country analysis of 478 patients</article-title>. <source>Ophthalmology</source>. (<year>2021</year>) <volume>128</volume>(<issue>1</issue>):<fpage>130</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.ophtha.2020.07.026</pub-id><pub-id pub-id-type="pmid">32682835</pub-id></citation></ref>
<ref id="B33"><label>33.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>Z</given-names></name><name><surname>Tang</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Qu</surname><given-names>X</given-names></name><name><surname>Hu</surname><given-names>X</given-names></name><name><surname>Lu</surname><given-names>J</given-names></name></person-group>. <article-title>Classification of children with autism and typical development using eye-tracking data from face-to-face conversations: machine learning model development and performance evaluation</article-title>. <source>J Med Internet Res</source>. (<year>2021</year>) <volume>23</volume>(<issue>8</issue>):<fpage>e29328</fpage>. <pub-id pub-id-type="doi">10.2196/29328</pub-id><pub-id pub-id-type="pmid">34435957</pub-id></citation></ref>
<ref id="B34"><label>34.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wen</surname><given-names>TH</given-names></name><name><surname>Cheng</surname><given-names>A</given-names></name><name><surname>Andreason</surname><given-names>C</given-names></name><name><surname>Zahiri</surname><given-names>J</given-names></name><name><surname>Xiao</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>R</given-names></name><etal/></person-group> <article-title>Large scale validation of an early-age eye-tracking biomarker of an autism spectrum disorder subtype</article-title>. <source>Sci Rep</source>. (<year>2022</year>) <volume>12</volume>(<issue>1</issue>):<fpage>4253</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-022-08102-6</pub-id><pub-id pub-id-type="pmid">35277549</pub-id></citation></ref>
<ref id="B35"><label>35.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tatham</surname><given-names>AJ</given-names></name><name><surname>Murray</surname><given-names>IC</given-names></name><name><surname>McTrusty</surname><given-names>AD</given-names></name><name><surname>Cameron</surname><given-names>LA</given-names></name><name><surname>Perperidis</surname><given-names>A</given-names></name><name><surname>Brash</surname><given-names>HM</given-names></name><etal/></person-group> <article-title>A case control study examining the feasibility of using eye tracking perimetry to differentiate patients with glaucoma from healthy controls</article-title>. <source>Sci Rep</source>. (<year>2021</year>) <volume>11</volume>(<issue>1</issue>):<fpage>839</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-020-80401-2</pub-id><pub-id pub-id-type="pmid">33436922</pub-id></citation></ref>
<ref id="B36"><label>36.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Economides</surname><given-names>JR</given-names></name><name><surname>Dilbeck</surname><given-names>MD</given-names></name><name><surname>Gentry</surname><given-names>TN</given-names></name><name><surname>Horton</surname><given-names>JC</given-names></name></person-group>. <article-title>Ambulatory monitoring with eye tracking glasses to assess the severity of intermittent exotropia</article-title>. <source>Am J Ophthalmol</source>. (<year>2023</year>) <volume>250</volume>:<fpage>120</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajo.2023.01.014</pub-id><pub-id pub-id-type="pmid">36681174</pub-id></citation></ref>
<ref id="B37"><label>37.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wen</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>B</given-names></name><name><surname>Cui</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>X</given-names></name></person-group>. <article-title>An automated method for assessing visual acuity in infants and toddlers using an eye-tracking system</article-title>. <source>JOVE-J Vis Exp</source>. (<year>2023</year>) (<issue>193</issue>):<fpage>e65274</fpage>. <pub-id pub-id-type="doi">10.3791/65274</pub-id></citation></ref>
<ref id="B38"><label>38.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ahmed</surname><given-names>IA</given-names></name><name><surname>Senan</surname><given-names>EM</given-names></name><name><surname>Rassem</surname><given-names>TH</given-names></name><name><surname>Ali</surname><given-names>MAH</given-names></name><name><surname>Shatnawi</surname><given-names>HSA</given-names></name><name><surname>Alwazer</surname><given-names>SM</given-names></name><etal/></person-group> <article-title>Eye tracking-based diagnosis and early detection of autism Spectrum disorder using machine learning and deep learning techniques</article-title>. <source>Electronics (Basel)</source>. (<year>2022</year>) <volume>11</volume>(<issue>4</issue>):<fpage>530</fpage>. <pub-id pub-id-type="doi">10.3390/electronics11040530</pub-id></citation></ref>
<ref id="B39"><label>39.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname><given-names>F</given-names></name><name><surname>Zheng</surname><given-names>D</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Duan</surname><given-names>J</given-names></name><name><surname>Guo</surname><given-names>Y</given-names></name><etal/></person-group> <article-title>Choroidal and retinal thickness and axial eye elongation in Chinese junior students</article-title>. <source>Invest Ophthalmol Vis Sci</source>. (<year>2021</year>) <volume>62</volume>(<issue>9</issue>):<fpage>26</fpage>. <pub-id pub-id-type="doi">10.1167/iovs.62.9.26</pub-id><pub-id pub-id-type="pmid">34279570</pub-id></citation></ref>
<ref id="B40"><label>40.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>M</given-names></name><name><surname>Yu</surname><given-names>X</given-names></name><name><surname>Wan</surname><given-names>M</given-names></name><name><surname>Feng</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Shen</surname><given-names>M</given-names></name><etal/></person-group> <article-title>Two-year longitudinal change in choroidal and retinal thickness in school-aged myopic children: exploratory analysis of clinical trials for myopia progression</article-title>. <source>EYE Vis</source>. (<year>2022</year>) <volume>9</volume>(<issue>1</issue>):<fpage>5</fpage>. <pub-id pub-id-type="doi">10.1186/s40662-022-00276-4</pub-id></citation></ref>
<ref id="B41"><label>41.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Gao</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Zhao</surname><given-names>Q</given-names></name></person-group>. <article-title>Choroidal thickness in relation to diopter and axial length among myopic children</article-title>. <source>Front Med</source>. (<year>2023</year>) <volume>10</volume>:<fpage>1241352</fpage>. <pub-id pub-id-type="doi">10.3389/fmed.2023.1241352</pub-id></citation></ref>
<ref id="B42"><label>42.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>Z</given-names></name><name><surname>Hou</surname><given-names>A</given-names></name><name><surname>Zhang</surname><given-names>T</given-names></name><name><surname>Lai</surname><given-names>Y</given-names></name><name><surname>Huang</surname><given-names>L</given-names></name><name><surname>Ding</surname><given-names>X</given-names></name></person-group>. <article-title>Pattern of choroidal thickness in early-onset high myopia</article-title>. <source>Front Med</source>. (<year>2023</year>) <volume>10</volume>:<fpage>1156259</fpage>. <pub-id pub-id-type="doi">10.3389/fmed.2023.1156259</pub-id></citation></ref>
<ref id="B43"><label>43.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Summers</surname><given-names>A</given-names></name><name><surname>Kuo</surname><given-names>A</given-names></name><name><surname>Zaback</surname><given-names>T</given-names></name><name><surname>Loh</surname><given-names>AR</given-names></name><name><surname>Brinks</surname><given-names>M</given-names></name><name><surname>Hribar</surname><given-names>MR</given-names></name></person-group>. <article-title>Pediatric ophthalmology provider and staff attitudes and patient satisfaction in telehealth implementation during COVID-19</article-title>. <source>Telemed E-Health</source>. (<year>2022</year>) <volume>28</volume>(<issue>5</issue>):<fpage>675</fpage>&#x2013;<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1089/tmj.2021.0189</pub-id></citation></ref>
<ref id="B44"><label>44.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ramsay</surname><given-names>C</given-names></name><name><surname>Murchison</surname><given-names>AP</given-names></name><name><surname>Bilyk</surname><given-names>JR</given-names></name></person-group>. <article-title>Pediatric eye emergency department visits: retrospective review and evaluation</article-title>. <source>J Pediatr Ophthalmol Strabismus</source>. (<year>2021</year>) <volume>58</volume>(<issue>2</issue>):<fpage>84</fpage>&#x2013;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.3928/01913913-20201118-01</pub-id><pub-id pub-id-type="pmid">34038266</pub-id></citation></ref>
<ref id="B45"><label>45.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kalita</surname><given-names>IR</given-names></name><name><surname>Veena</surname><given-names>K</given-names></name><name><surname>Mouttappa</surname><given-names>F</given-names></name><name><surname>Singh</surname><given-names>H</given-names></name></person-group>. <article-title>A study of referral pattern to pediatric ophthalmology department in a tertiary eye-care center of south-India</article-title>. <source>Indian J Ophthalmol</source>. (<year>2022</year>) <volume>70</volume>(<issue>1</issue>):<fpage>223</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.4103/ijo.IJO_1446_21</pub-id><pub-id pub-id-type="pmid">34937242</pub-id></citation></ref>
<ref id="B46"><label>46.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Walsh</surname><given-names>HL</given-names></name><name><surname>Parrish</surname><given-names>A</given-names></name><name><surname>Hucko</surname><given-names>L</given-names></name><name><surname>Sridhar</surname><given-names>J</given-names></name><name><surname>Cavuoto</surname><given-names>KM</given-names></name></person-group>. <article-title>Access to pediatric ophthalmological care by geographic distribution and US population demographic characteristics in 2022</article-title>. <source>JAMA Ophthalmol</source>. (<year>2023</year>) <volume>141</volume>(<issue>3</issue>):<fpage>242</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1001/jamaophthalmol.2022.6010</pub-id><pub-id pub-id-type="pmid">36701149</pub-id></citation></ref>
<ref id="B47"><label>47.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gautam</surname><given-names>N</given-names></name><name><surname>Ram</surname><given-names>R</given-names></name><name><surname>Bustamante</surname><given-names>E</given-names></name><name><surname>Sharrah</surname><given-names>D</given-names></name><name><surname>Mets-Halgrimson</surname><given-names>R</given-names></name></person-group>. <article-title>Pediatric ophthalmology inpatient consults at a tertiary care children&#x2019;s hospital</article-title>. <source>J AAPOS</source>. (<year>2023</year>) <volume>27</volume>(<issue>2</issue>):<fpage>004</fpage>. <pub-id pub-id-type="doi">10.1016/j.jaapos.2022.12.004</pub-id></citation></ref>
<ref id="B48"><label>48.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>KE</given-names></name><name><surname>Sussberg</surname><given-names>JA</given-names></name><name><surname>Nelson</surname><given-names>LB</given-names></name><name><surname>Thuma</surname><given-names>T</given-names></name></person-group>. <article-title>The economic downturn of pediatric ophthalmology and its impact on access to eye care</article-title>. <source>J Pediatr Ophthalmol Strabismus</source>. (<year>2023</year>) <volume>60</volume>(<issue>1</issue>):<fpage>18</fpage>&#x2013;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.3928/01913913-20221108-01</pub-id><pub-id pub-id-type="pmid">36441126</pub-id></citation></ref>
<ref id="B49"><label>49.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Luccarelli</surname><given-names>S</given-names></name><name><surname>Lucentini</surname><given-names>S</given-names></name><name><surname>Martellucci</surname><given-names>CA</given-names></name><name><surname>Marelli</surname><given-names>L</given-names></name><name><surname>Sacchi</surname><given-names>M</given-names></name><name><surname>Nucci</surname><given-names>P</given-names></name></person-group>. <article-title>Impact of adherence (compliance) to oral Acyclovir prophylaxis in the recurrence of herpetic keratitis: long-term results from a pediatric cohort</article-title>. <source>Cornea</source>. (<year>2021</year>) <volume>40</volume>(<issue>9</issue>):<fpage>1126</fpage>&#x2013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1097/ICO.0000000000002578</pub-id><pub-id pub-id-type="pmid">33201055</pub-id></citation></ref>
<ref id="B50"><label>50.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shah</surname><given-names>K</given-names></name><name><surname>Camhi</surname><given-names>SS</given-names></name><name><surname>Sridhar</surname><given-names>J</given-names></name><name><surname>Cavuoto</surname><given-names>KM</given-names></name></person-group>. <article-title>Impact of the coronavirus pandemic on pediatric eye-related emergency department services</article-title>. <source>J AAPOS</source>. (<year>2020</year>) <volume>24</volume>(<issue>6</issue>):<fpage>367</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaapos.2020.09.001</pub-id><pub-id pub-id-type="pmid">33144199</pub-id></citation></ref>
<ref id="B51"><label>51.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>da Silva</surname><given-names>AO</given-names></name><name><surname>Rolim-de-Moura</surname><given-names>C</given-names></name><name><surname>Botelho</surname><given-names>NLP</given-names></name><name><surname>Gracitelli</surname><given-names>CPB</given-names></name><name><surname>Ferraz</surname><given-names>NN</given-names></name></person-group>. <article-title>Psychosocial indicators of primary congenital glaucoma and filtering surgeries impacts on children and family&#x2019;s quality of life</article-title>. <source>Eur J Ophthalmol</source>. (<year>2022</year>) <volume>32</volume>(<issue>4</issue>):<fpage>1997</fpage>&#x2013;<lpage>2004</lpage>. <pub-id pub-id-type="doi">10.1177/11206721211048358</pub-id><pub-id pub-id-type="pmid">34615405</pub-id></citation></ref>
<ref id="B52"><label>52.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sayed Y</surname><given-names>E</given-names></name><name><surname>Esmael</surname><given-names>A</given-names></name><name><surname>Mettias</surname><given-names>N</given-names></name><name><surname>El Sanabary</surname><given-names>Z</given-names></name><name><surname>Gawdat</surname><given-names>G</given-names></name></person-group>. <article-title>Factors influencing the outcome of goniotomy and trabeculotomy in primary congenital glaucoma</article-title>. <source>Br J Ophthalmol</source>. (<year>2021</year>) <volume>105</volume>(<issue>9</issue>):<fpage>1250</fpage>&#x2013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1136/bjophthalmol-2018-313387</pub-id><pub-id pub-id-type="pmid">30846492</pub-id></citation></ref>
<ref id="B53"><label>53.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mandal</surname><given-names>AK</given-names></name><name><surname>Gothwal</surname><given-names>VK</given-names></name><name><surname>Khanna</surname><given-names>R</given-names></name></person-group>. <article-title>Combined trabeculotomy-trabeculectomy for primary congenital glaucoma: long-term experience from a tertiary referral centre in a developing nation</article-title>. <source>Acta Ophthalmol (Copenh)</source>. (<year>2022</year>) <volume>100</volume>(<issue>2</issue>):<fpage>E439</fpage>&#x2013;<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1111/aos.14984</pub-id></citation></ref>
<ref id="B54"><label>54.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kaushik</surname><given-names>S</given-names></name><name><surname>Gupta</surname><given-names>G</given-names></name><name><surname>Thattaruthody</surname><given-names>F</given-names></name><name><surname>Dhingra</surname><given-names>D</given-names></name><name><surname>Kumari</surname><given-names>K</given-names></name><name><surname>Arora</surname><given-names>A</given-names></name><etal/></person-group> <article-title>Goniotomy for initial and re-surgery for childhood glaucoma in northern India</article-title>. <source>Indian J Ophthalmol</source>. (<year>2021</year>) <volume>69</volume>(<issue>8</issue>):<fpage>2088</fpage>&#x2013;<lpage>94</lpage>. <pub-id pub-id-type="doi">10.4103/ijo.IJO_3305_20</pub-id><pub-id pub-id-type="pmid">34304184</pub-id></citation></ref>
<ref id="B55"><label>55.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Promelle</surname><given-names>V</given-names></name><name><surname>Lyons</surname><given-names>CJ</given-names></name></person-group>. <article-title>Long-term results of ahmed valve implantation with mitomycin-C in pediatric glaucoma</article-title>. <source>J Glaucoma</source>. (<year>2021</year>) <volume>30</volume>(<issue>7</issue>):<fpage>596</fpage>&#x2013;<lpage>605</lpage>. <pub-id pub-id-type="doi">10.1097/IJG.0000000000001881</pub-id><pub-id pub-id-type="pmid">33979112</pub-id></citation></ref>
<ref id="B56"><label>56.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jacobson</surname><given-names>A</given-names></name><name><surname>Rojas</surname><given-names>C</given-names></name><name><surname>Bohnsack</surname><given-names>BL</given-names></name></person-group>. <article-title>Ologen augmentation of ahmed glaucoma drainage devices in pediatric glaucomas</article-title>. <source>BMC Ophthalmol</source>. (<year>2021</year>) <volume>21</volume>(<issue>1</issue>):<fpage>72</fpage>. <pub-id pub-id-type="doi">10.1186/s12886-021-01827-4</pub-id><pub-id pub-id-type="pmid">33546636</pub-id></citation></ref>
<ref id="B57"><label>57.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jacobson</surname><given-names>A</given-names></name><name><surname>Besirli</surname><given-names>CG</given-names></name><name><surname>Bohnsack</surname><given-names>BL</given-names></name></person-group>. <article-title>Outcomes of baerveldt glaucoma drainage devices in pediatric eyes</article-title>. <source>J Glaucoma</source>. (<year>2022</year>) <volume>31</volume>(<issue>6</issue>):<fpage>468</fpage>&#x2013;<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1097/IJG.0000000000001970</pub-id><pub-id pub-id-type="pmid">34930874</pub-id></citation></ref>
<ref id="B58"><label>58.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wagner</surname><given-names>FM</given-names></name><name><surname>Schuster</surname><given-names>AK</given-names></name><name><surname>Grehn</surname><given-names>F</given-names></name><name><surname>Urbanek</surname><given-names>L</given-names></name><name><surname>Pfeiffer</surname><given-names>N</given-names></name><name><surname>Stingl</surname><given-names>JV</given-names></name><etal/></person-group> <article-title>Twenty-years of experience in childhood glaucoma surgery</article-title>. <source>J Clin Med</source>. (<year>2021</year>) <volume>10</volume>(<issue>24</issue>):<fpage>5720</fpage>. <pub-id pub-id-type="doi">10.3390/jcm10245720</pub-id><pub-id pub-id-type="pmid">34945031</pub-id></citation></ref>
<ref id="B59"><label>59.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ruparelia</surname><given-names>S</given-names></name><name><surname>Berco</surname><given-names>E</given-names></name><name><surname>Lichtinger</surname><given-names>A</given-names></name><name><surname>Shoham-Hazon</surname><given-names>N</given-names></name></person-group>. <article-title>Multiple XEN gel stents for refractory pediatric glaucoma</article-title>. <source>J Pediatr Ophthalmol Strabismus</source>. (<year>2022</year>) <volume>59</volume>(<issue>1</issue>):<fpage>E11</fpage>&#x2013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.3928/01913913-20211101-03</pub-id><pub-id pub-id-type="pmid">35072554</pub-id></citation></ref>
<ref id="B60"><label>60.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Le</surname><given-names>R</given-names></name><name><surname>Xie</surname><given-names>Y</given-names></name><name><surname>Cheng</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Ye</surname><given-names>W</given-names></name><name><surname>Deng</surname><given-names>Y</given-names></name><etal/></person-group> <article-title>Outcomes of penetrating canaloplasty in childhood glaucoma</article-title>. <source>J Glaucoma</source>. (<year>2023</year>) <volume>32</volume>(<issue>1</issue>):<fpage>34</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1097/IJG.0000000000002111</pub-id><pub-id pub-id-type="pmid">35980844</pub-id></citation></ref>
<ref id="B61"><label>61.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gusson</surname><given-names>E</given-names></name><name><surname>Chemello</surname><given-names>F</given-names></name><name><surname>Longo</surname><given-names>R</given-names></name><name><surname>Franzolin</surname><given-names>E</given-names></name><name><surname>Vesentini</surname><given-names>R</given-names></name><name><surname>Verlato</surname><given-names>G</given-names></name><etal/></person-group> <article-title>Primary congenital glaucoma surgery: outcomes and visual function</article-title>. <source>Int Ophthalmol</source>. (<year>2021</year>) <volume>41</volume>(<issue>11</issue>):<fpage>3861</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1007/s10792-021-01957-0</pub-id><pub-id pub-id-type="pmid">34297306</pub-id></citation></ref>
<ref id="B62"><label>62.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alshigari</surname><given-names>R</given-names></name><name><surname>Freidi</surname><given-names>A</given-names></name><name><surname>Souru</surname><given-names>C</given-names></name><name><surname>Edward</surname><given-names>DP</given-names></name><name><surname>Malik</surname><given-names>R</given-names></name></person-group>. <article-title>Risk factors for blindness in children with primary congenital glaucoma - follow-up of a registry cohort</article-title>. <source>Am J Ophthalmol</source>. (<year>2021</year>) <volume>224</volume>:<fpage>238</fpage>&#x2013;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajo.2020.12.014</pub-id><pub-id pub-id-type="pmid">33359680</pub-id></citation></ref>
<ref id="B63"><label>63.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stingl</surname><given-names>JV</given-names></name><name><surname>Diederich</surname><given-names>S</given-names></name><name><surname>Diel</surname><given-names>H</given-names></name><name><surname>Schuster</surname><given-names>AK</given-names></name><name><surname>Wagner</surname><given-names>FM</given-names></name><name><surname>Chronopoulos</surname><given-names>P</given-names></name><etal/></person-group> <article-title>First results from the prospective German registry for childhood glaucoma: phenotype-genotype association</article-title>. <source>J Clin Med</source>. (<year>2022</year>) <volume>11</volume>(<issue>1</issue>):<fpage>16</fpage>. <pub-id pub-id-type="doi">10.3390/jcm11010016</pub-id></citation></ref>
<ref id="B64"><label>64.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tehreem</surname><given-names>R</given-names></name><name><surname>Arooj</surname><given-names>A</given-names></name><name><surname>Siddiqui</surname><given-names>SN</given-names></name><name><surname>Naz</surname><given-names>S</given-names></name><name><surname>Afshan</surname><given-names>K</given-names></name><name><surname>Firasat</surname><given-names>S</given-names></name></person-group>. <article-title>Mutation screening of the CYP1B1 gene reveals thirteen novel disease-causing variants in consanguineous Pakistani families causing primary congenital glaucoma</article-title>. <source>PLoS One</source>. (<year>2022</year>) <volume>17</volume>(<issue>9</issue>):<fpage>e0274335</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0274335</pub-id><pub-id pub-id-type="pmid">36083974</pub-id></citation></ref>
<ref id="B65"><label>65.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yam</surname><given-names>JC</given-names></name><name><surname>Jiang</surname><given-names>Y</given-names></name><name><surname>Tang</surname><given-names>SM</given-names></name><name><surname>Law</surname><given-names>AKP</given-names></name><name><surname>Chan</surname><given-names>JJ</given-names></name><name><surname>Wong</surname><given-names>E</given-names></name><etal/></person-group> <article-title>Low-concentration atropine for myopia progression (LAMP) study A randomized, double-blinded, placebo-controlled trial of 0.05&#x0025;, 0.025&#x0025;, and 0.01&#x0025; atropine eye drops in myopia control</article-title>. <source>Ophthalmology</source>. (<year>2019</year>) <volume>126</volume>(<issue>1</issue>):<fpage>113</fpage>&#x2013;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1016/j.ophtha.2018.05.029</pub-id><pub-id pub-id-type="pmid">30514630</pub-id></citation></ref>
<ref id="B66"><label>66.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ramanan</surname><given-names>AV</given-names></name><name><surname>Dick</surname><given-names>AD</given-names></name><name><surname>Jones</surname><given-names>AP</given-names></name><name><surname>McKay</surname><given-names>A</given-names></name><name><surname>Williamson</surname><given-names>PR</given-names></name><name><surname>Compeyrot-Lacassagne</surname><given-names>S</given-names></name><etal/></person-group> <article-title>Adalimumab plus methotrexate for uveitis in juvenile idiopathic arthritis</article-title>. <source>N Engl J Med</source>. (<year>2017</year>) <volume>376</volume>(<issue>17</issue>):<fpage>1637</fpage>&#x2013;<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa1614160</pub-id><pub-id pub-id-type="pmid">28445659</pub-id></citation></ref>
<ref id="B67"><label>67.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Morin</surname><given-names>J</given-names></name><name><surname>Luu</surname><given-names>TM</given-names></name><name><surname>Superstein</surname><given-names>R</given-names></name><name><surname>Ospina</surname><given-names>LH</given-names></name><name><surname>Lefebvre</surname><given-names>F</given-names></name><name><surname>Simard</surname><given-names>MN</given-names></name><etal/></person-group> <article-title>Neurodevelopmental outcomes following bevacizumab injections for retinopathy of prematurity</article-title>. <source>Pediatrics</source>. (<year>2016</year>) <volume>137</volume>(<issue>4</issue>):<fpage>e20153218</fpage>. <pub-id pub-id-type="doi">10.1542/peds.2015-3218</pub-id><pub-id pub-id-type="pmid">27244705</pub-id></citation></ref>
<ref id="B68"><label>68.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ventura</surname><given-names>CV</given-names></name><name><surname>Maia</surname><given-names>M</given-names></name><name><surname>Ventura</surname><given-names>BV</given-names></name><name><surname>Linden</surname><given-names>VV</given-names></name><name><surname>Ara&#x00FA;jo</surname><given-names>EB</given-names></name><name><surname>Ramos</surname><given-names>RC</given-names></name><etal/></person-group> <article-title>Ophthalmological findings in infants with microcephaly and presumable intra-uterus Zika virus infection</article-title>. <source>Arq Bras Oftalmol</source>. (<year>2016</year>) <volume>79</volume>(<issue>1</issue>):<fpage>1</fpage>&#x2013;<lpage>3</lpage>. <pub-id pub-id-type="doi">10.5935/0004-2749.20160002</pub-id><pub-id pub-id-type="pmid">26840156</pub-id></citation></ref>
<ref id="B69"><label>69.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stahl</surname><given-names>A</given-names></name><name><surname>Lepore</surname><given-names>D</given-names></name><name><surname>Fielder</surname><given-names>A</given-names></name><name><surname>Fleck</surname><given-names>B</given-names></name><name><surname>Reynolds</surname><given-names>JD</given-names></name><name><surname>Chiang</surname><given-names>MF</given-names></name><etal/></person-group> <article-title>Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial</article-title>. <source>Lancet</source>. (<year>2019</year>) <volume>394</volume>(<issue>10208</issue>):<fpage>1551</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(19)31344-3</pub-id><pub-id pub-id-type="pmid">31522845</pub-id></citation></ref>
<ref id="B70"><label>70.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pierce</surname><given-names>K</given-names></name><name><surname>Marinero</surname><given-names>S</given-names></name><name><surname>Hazin</surname><given-names>R</given-names></name><name><surname>McKenna</surname><given-names>B</given-names></name><name><surname>Barnes</surname><given-names>CC</given-names></name><name><surname>Malige</surname><given-names>A</given-names></name></person-group>. <article-title>Eye tracking reveals abnormal visual preference for geometric images as an early biomarker of an autism Spectrum disorder subtype associated with increased symptom severity</article-title>. <source>Biol Psychiatry</source>. (<year>2016</year>) <volume>79</volume>(<issue>8</issue>):<fpage>657</fpage>&#x2013;<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2015.03.032</pub-id><pub-id pub-id-type="pmid">25981170</pub-id></citation></ref>
<ref id="B71"><label>71.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Webb</surname><given-names>AH</given-names></name><name><surname>Gao</surname><given-names>BT</given-names></name><name><surname>Goldsmith</surname><given-names>ZK</given-names></name><name><surname>Irvine</surname><given-names>AS</given-names></name><name><surname>Saleh</surname><given-names>N</given-names></name><name><surname>Lee</surname><given-names>RP</given-names></name><etal/></person-group> <article-title>Inhibition of MMP-2 and MMP-9 decreases cellular migration, and angiogenesis in in vitro models of retinoblastoma</article-title>. <source>BMC Cancer</source>. (<year>2017</year>) <volume>17</volume>:<fpage>434</fpage>. <pub-id pub-id-type="doi">10.1186/s12885-017-3418-y</pub-id><pub-id pub-id-type="pmid">28633655</pub-id></citation></ref>
<ref id="B72"><label>72.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wallace</surname><given-names>DK</given-names></name><name><surname>Dean</surname><given-names>TW</given-names></name><name><surname>Hartnett</surname><given-names>ME</given-names></name><name><surname>Kong</surname><given-names>L</given-names></name><name><surname>Smith</surname><given-names>LE</given-names></name><name><surname>Hubbard</surname><given-names>GB</given-names></name><etal/></person-group> <article-title>A dosing study of bevacizumab for retinopathy of prematurity late recurrences and additional treatments</article-title>. <source>Ophthalmology</source>. (<year>2018</year>) <volume>125</volume>(<issue>12</issue>):<fpage>1961</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/j.ophtha.2018.05.001</pub-id><pub-id pub-id-type="pmid">29887334</pub-id></citation></ref>
<ref id="B73"><label>73.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hwang</surname><given-names>CK</given-names></name><name><surname>Hubbard</surname><given-names>GB</given-names></name><name><surname>Hutchinson</surname><given-names>AK</given-names></name><name><surname>Lambert</surname><given-names>SR</given-names></name></person-group>. <article-title>Outcomes after intravitreal evacizumab versus Laser photocoagulation for retinopathy of prematurity A 5-year retrospective analysis</article-title>. <source>Ophthalmology</source>. (<year>2015</year>) <volume>122</volume>(<issue>5</issue>):<fpage>1008</fpage>&#x2013;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1016/j.ophtha.2014.12.017</pub-id><pub-id pub-id-type="pmid">25687024</pub-id></citation></ref>
<ref id="B74"><label>74.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>JX</given-names></name><name><surname>Hua</surname><given-names>WJ</given-names></name><name><surname>Jiang</surname><given-names>X</given-names></name><name><surname>Wu</surname><given-names>XY</given-names></name><name><surname>Yang</surname><given-names>JW</given-names></name><name><surname>Gao</surname><given-names>GP</given-names></name><etal/></person-group> <article-title>Effect of outdoor activity on myopia onset and progression in school-aged children in northeast China: the sujiatun eye care study</article-title>. <source>BMC Ophthalmol</source>. (<year>2015</year>) <volume>15</volume>:<fpage>73</fpage>. <pub-id pub-id-type="doi">10.1186/s12886-015-0052-9</pub-id></citation></ref></ref-list>
</back>
</article>